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ABSTRACT
NORADRENERGIC REGULATION OF SEROTONERGIC NEURONS IN THE DORSAL RAPHE:
PHYSIOLOGICAL, PHARMACOLOGICAL AND ANATOMICAL STUDIES
Jay Matthew Baraban
Yale University 1980
Recent pharmacological studies suggest that a central nor¬
adrenergic (NE) system regulates the firing activity of the serotonin
(5-HT)-containing neurons in the dorsal raphe nucleus.

Reduction

of noradrenergic tone by a variety of pharmacological interventions
leads to a suppression of 5-HT cell firing (Svensson et al., 1975).
It has been suggested that an alpha-adrenoceptor mediates NE's
effects since systemic administration of an alpha-adrenoceptor
antagonist, piperoxan, reduces 5-HT cell firing (Gallager and
Aghajanian, 1976a).

Since the dorsal raphe receives a prominent

noradrenergic innervation (Fuxe, 1965), these noradrenergic terminals
could mediate the noradrenergic regulation of 5-HT neuron firing
activity.
This dissertation will present studies which are aimed at:
^demonstrating that the NE innervation of the dorsal raphe does
regulate 5-HT cell firing,

2) characterizing the pharmacology of

the noradrenergic control of 5-HT cell activity, and

3) elucidating

the local synaptic circuitry underlying NE's action on 5-HT cells
of the dorsal raphe.
The first set of experiments provides evidence that the
activity of 5-HT cells is regulated by the NE innervation of the
dorsal raphe.

Earlier studies showed that reserpine suppresses

5-HT cell firing activity (Aghajanian and Haigler, 1972).

Studies

will be presented which indicate that this action of reserpine is
due to its interference with central noradrenergic transmission.
In order to determine whether restoration of NE tone within the
dorsal raphe could restore 5-HT cell firing, NE was administered
by iontophoresis in the vicinity of 5-HT cells during their
suppression by reserpine.

Small amounts of NE restored 5-HT cell

firing to normal or above normal levels.

This observation suggests

that NE released locally in the dorsal raphe maintains the tonic
activity of 5-HT cells.
A second series of experiments characterizes pharmacologically
the receptor mediating NE's activation of 5-HT cell activity.

Alpha-

adrenoceptor antagonists were found to block NE's activation of 5-HT
cell firing.

Also, these drugs suppressed spontaneous firing of 5-HT

cells when applied iontophoretically.

These findings suggest that

alpha-adrenoceptors present in the dorsal raphe mediate NE's action
on 5-HT cells.

The measurement of the relative potencies of a

series of agonists in activating 5-HT cells suggests that the alphaadrenoceptor mediating NE's action can be classified in the alpha-1adrenoceptor category.
The results of earlier physiological studies led to the proposal
that GABA interneurons present in the dorsal raphe mediate NE's
regulation of 5-HT cell firing (Gallager and Aghajanian, 1976b).
Another group of experiments tests this hypothesis by examining the
effect of GABA receptor antagonists on NE's regulation of 5-HT cell
firing.

Application of these drugs by iontophoresis did not inter¬

fere with the suppression of 5-HT cell firing produced by alphaadrenoceptor antagonists.

This finding suggests that NE's regulation

of 5-HT cell firing is not mediated by GABA.
The dorsal raphe contains both non-serotonergic, as well as
serotonergic neurons (Aghajanian et al., 1978).

Therefore, the

effects of NE on 5-HT cells could stem from a direct innervation
of 5-HT cells, or alternatively, could be mediated indirectly by
non-serotonergic neuronal elements.

Anatomical experiments will

be presented which provide evidence that NE's activation of 5-HT
cells results from a direct NE innervation.

NE terminals in the

dorsal raphe were identified by electron microscopic autoradiography.
Futhermore, neuronal elements were classified as either serotonergic
or non-serotonergic following treatment with the selective serotonin
neurotoxin, 5,7-dihydroxytryptamine.

A majority of the post-

synaptic elements innervated by NE terminals displayed signs of
degeneration.

This observation suggests that NE terminals directly

innervate 5-HT neurons of the dorsal raphe.
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INTRODUCTION

I.

Rationale
Despite disagreement over the exact criteria which define a

neurotransmitter, there is overwhelming experimental support for
the assertion that serotonin (5-HT) is a transmitter in the central
nervous system.

Since the detection of 5-HT in mammalian brain,

(Twarog and Page, 1953; Amin et al., 1954) the brain's ability to
synthesize serotonin from tryptophan (Gal et al., 1963; GrahameSmith, 1964, 1967) to release it upon electrical stimulation
(Chase et al., 1969; Holman and Vogt, 1972), and to inactivate
it by a high-affinity uptake system (Blackburn et al., 1967; Ross
and Renyi, 1967) have been well established.

A major advance in

the study of central 5-HT systems followed upon the application
of the formaldehyde-condensation histochemical method (Falck et.
al., 1962) to brain.

This technigue allowed the visualization

of 5-HT cell bodies (Dahlstrom and Fuxe, 1964) terminals
(Aghajanian et al., 1973,
al., 1966).

Fuxe, 1965) and pathways (Anden et

This anatomical information directed study to the

physiological effect of 5-HT in areas which receive a dense and uniform
5-HT innervation.

Exogenous application of 5-HT in densely innervated

forebrain areas, invariably inhibited neuronal firing (Bloom et al. ,
1972b; Haigler and Aghajanian, 1974b).

Recent studies of the

effect of 5-HT on facial motoneurons have demonstrated that 5-HT
enhances the excitability of these cells by a receptor mediated
mechanism (McCall and Aghajanian, 1979).
Perhaps, the most essential criterion which a transmitter
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candidate must fulfill is the demonstration that the exogenously
applied putative transmitter "mimics" the effect of pathway stimula¬
tion.

Since histofluorescence(Aghajanian et al., 1973; Anden et

al., 1966) and autoradiographic studies (Conrad et al., 1974;
Bobillier et al., 1976) had identified the presence of a 5-HT path¬
way from the midbrain raphe to the amygdala, this criterion could
be examined.

Stimulation of the afferent 5-HT pathway to the

amygdala markedly depressed neuronal firing, effectively mimicking
the inhibitory action of exogenously applied 5-HT (Wang and
Aghajanian, 1977d). In that study, the authors provide strong
support for the idea that the release of 5-HT by pathway stimula¬
tion produced the inhibition.

Selective destruction of 5-HT

fibers by injection of 5,7-dihydroxytryptamine (5,7-DHT), a 5-HT
neurotoxin (Baumgarten and Lachenmeyer, 1972) prevented the
stimulation-induced inhibition, as did depletion of serotonin
levels by pretreatment with parachlorophenylalanine, PCPA, an
inhibitor of 5-HT synthesis (Jequier et al., 1967).

In addition,

application of a 5-HT high-affinity uptake blocker, chiorimipramine,
(Carlsson, 1970; Ross and Renyi, 1969) prolonged the effects of
both 5-HT pathway stimulation and application of exogenous 5-HT.
Taken together, the findings described above provide evidence that
serotonin acts as a neurotransmitter in the mammalian brain.
5-HT-containing neurons of the brain are located primarily
within the brain stem raphe nuclei

(Dahlstrom and Fuxe, 1964) and

project widely throughout the central nervous system

(Fuxe, 1965).

Substantial evidence suggests that these neurons play an important
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role in a wide range of physiological functions.

Several studies

indicate that the 5-HT system regulates the release of a variety of
pituitary hormones including FSH, LH, prolactin and ACTH (Chase and
Murphy, 1973).

The remarkable finding that 5-HT cells retain a

tonic firing rate except during periods of REM sleep (McGinty and
Harper, 1976; Trulson and Jacobs, 1979) suggests that they play a
special role in the physiology of the sleep-waking cycle.

In

addition, behavioral studies support the notion that increased 5-HT
tone suppresses pain perception (Chase and Murphy, 1973).
The relationship of the serotonin system to behavioral disorders
has received special attention.

Administration of PCPA, which blocks

5-HT synthesis, unmasks aggressive and hypersexual behavior (Sheard,
1969).

The hypothesis that decreased serotonergic transmission

underlies endogenous depression in a subgroup of patients has
gained acceptance (Coppen et a 1., 1972); drugs which enhance sero¬
tonergic transmission alleviate depressive symptoms, lending support
to this theory (Coppen et a 1., 1 963, 1 967).

The proposal that de¬

creased 5-HT transmission may be related to psychotic behavior was
inspired by studies which demonstrated an antagonism of 5-HT1 s
action by LSD and related hallucinogens (Wooley and Shaw, 1954;
Kety, 1959).

These observations suggest that disruptions of the

5-HT system may play an important role in certain behavioral dis¬
orders .
In the hope of aaining greater insight into the physiology and
pathophysiology of the 5-HT system, it is important to elucidate
the manner in which other neuronal systems influence the activity

4

of the 5-HT system.

In particular, the experiments presented in

thi s dissertationhave focussed on the regulation of the 5-HT system
by the noradrenergic systems located within the brain.
11.

NE Regulation of the 5-HT System: Anatomical and Biochemical
Studies
Fluorescent histochemical studies demonstrated the close

apposition of catecholamine nerve terminals and 5-HT cell bodies
(Fuxe, 1965).

Even though the cell bodies of the serotonin cells

are distributed throughout the brain stem among the midbrain raphe
nuclei, many of these nuclei were observed to contain catecholamine
terminals.

These studies first led to the suggestion that central

noradrenergic systems influence the 5-HT system.

More recent bio¬

chemical measurements have confirmed the presence of relatively
high NE concentrations in the raphe nuclei

(Saavedra et a 1., 1976;

Levitt and Moore, 1979).
The development

of a biochemical index of 5-HT cell activity

allowed further study of a possible functional link between these
systems.

The concept that increased 5-HT neuronal firing activity

produced elevated levels of 5-hydroxyindole acetic acid (5-HIAA),
a metabolite of 5-HT, had received experimental support from the
studies of Sheard and Aghajanian (1968).

They found that electrical

stimulation of the 5-HT cells of the midbrain raphe, which project
to the forebrain (Anden et al., 1966), produced marked elevations of
5-HIAA there.

Therefore, the effects on 5-HIAA levels of a variety

of treatments which interfere with NE activity were measured.
Lesions of the locus coeruleus, which projects extensively to the

5
forebrain (Anden et al., 1966) and administration of 6-OHDA, a selec¬
tive catecholamine neurotoxin (Malmfors andThoenen, 1971) were used
to deplete NE levels in the brain.

Both these treatments produced

increased levels of 5-HIAA (Kostowski et al., 1974; Blondaux et al.,
1973).

Other pharmacological manipulations of the NE system produced

a similar result.

Treatment with either a tyrosine hydroxylase inhi¬

bitor, alpha-methyl-paratyrosine (Stein et al., 1974) or a dopamine
beta hydroxylase inhibitor (Johnson et al., 1972) also increased
5-HIAA levels in the forebrain areas.

The general consensus of

these studies suggests that decreased NE tone tends to produce ele¬
vations of 5-HT turnover.

However, it must be emphasized that even

though stimulation of 5-HT pathways leads to elevated 5-HIAA, the
converse is not assured, i.e., increased 5-HIAA levels do not nec¬
essarily imply an increase in functional activity of the 5-HT system.
For example, administration of tryptophan suppresses 5-HT cell
firing (Aghajanian, 1 972b) yet elevates 5-HIAA levels (Moir and
Eccleston, 1968).

Indeed, in two of the four studies mentioned above,

levels of brain tryptophan were measured

and

were elevated

(Blondaux et al ., 1973; Stein et al., 1974), suggesting that the
elevations of 5-HIAA might be related to increased levels of pre¬
cursor tryptophan, rather than the increased impulse flow.
A more promising biochemical approach to determining the
functional activity of the 5-HT system involves measuring the dis¬
appearance of 5-HT from brain following inhibition of its synthetic
enzyme, tryptophan hydroxylase.

When this index of 5-HT utilization

was monitored, clonidine, an alpha-adrenergic agonist which reduces
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NE turnover, also slowed the disappearance of 5-HT, suggesting that
5-HT activity

decreases

in parallel with NE activity (Anden et al.,

1970; Scheel-Kruger, 1974).
III. Neurophysiological Studies of 5-HT Neurons
1.

Identification of 5-HT Neurons
Histofluorescence studies demonstrated the presence of a

dense cluster of 5-HT cells in the dorsal raphe nucleus (Dahlstrom
and Fuxe, 1964).

The successful application of extracel1ular re¬

cording techniques to these 5-HT neurons (Aghajanian, 1972a) allowed
the direct measurement of impulse activity in the 5-HT system.

These

cells display a character!stic slow (approximately 1 spike/sec),
regular firing rate and a wide action potential
them to

(1-2 msec) which allow

be tentatively identified as 5-HT cells during recording

experiments.

Routine histological examination of dye delivered from

recording electrodes demonstrated that the distribution of these
cells corresponds to that of 5-HT cells identified in histofluorescent
studies.

In addition, both physiological and anatomical methods

have been used to confirm the serotonergic identity of these neurons.
Iontophoretic ejection of 1-tryptophan from recording electrodes in
the vicinity of presumptively identified 5-HT neurons produced highly
fluorescent spots when the tissue was processed for histofluorescence
(Aghajanian and Haiqler, 1974).

This finding suggests that the

ejected tryptophan was taken up into 5-HT cells, since only these
neurons in brain are capable of converting 1-tryptophan to its
highly fluorescent endproduct 5-HT (Aghajanian and Asher, 1971).
Further evidence that these neurons are serotonergic was provided
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by el ectrophysiol ogical techniques.

The course of efferen-t 5-HT

fibers emerging from the dorsal raphe had been mapped by the
histof1uorescence method (Anden et a 1., 1 966).

Therefore, this

bundle could be stimulated electrically by an electrode stereotaxically positioned in its vicinity.

Stimulation of these fibers

initiates action potentials which travel both orthodromically as
well as antidromically back to the cell bodies.

Therefore, a

recording electrode located within the dorsal raphe can detect
the antidromically elicited spike.

In this way, it was found

that the presumptively identified 5-HT neurons can be antidromically activated by stimulation of the 5-HT pathway demonstrating
that they are serotonergic (Wang and Aghajanian, 1977c).

In a

later study, Aghajanian et al. (1978) found that following 5,7-DHT
treatment, which selectively damaged 5-HT cells, the activity of
slow and regularly firing cells of the dorsal raphe could not be
detected in routine recording experiments, further verifying the
serotonergic nature of these cells.

This body of evidence allows

the identification of serotonergic neurons in the dorsal raphe
with a high degree of certainty.
2.

Autoinhibition of 5-HT Cells
The 5-HT cells of the dorsal raphe possess a tonic, re¬

gular firing rate.

In an effort to gain a greater understanding of

the function of the 5-HT system, a variety of studies have been
aimed at identifying factors that affect 5-HT cell firing activity.
To this end, the actions on 5-HT cells of both systemically and
locally applied drugs have been examined.

Since 5-HT cells fire
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at a remarkably constant rate, it is possible to ascertain the base¬
line firing rate of an individual cell, administer a drug systemically
or iontophoretically, and monitor the cell's response to the drug
treatment.
Systemically applied drugs which increase the availability of 5-HT
at 5-HT receptors lead to a suppression of 5-HT cell firing.

Systemic

administration of tryptophan accelerates the synthesis of 5-HT
(Eccleston et a 1. , 1965), presumably because tryptophan hydroxylase,
the rate limiting enzyme in 5-HT synthesis, is not normally saturated
with its substrate tryptophan (Green and Grahame-Smith, 1975).
treatment reduces 5-HT cell activity (Aghajanian, 1972b).

This

Also,

administration of either 5-HT uptake inhibitors, which are thought to
increase the amount of 5-HT available to stimulate post-synaptic
receptors, or parachloramphetamine, which releases 5-HT, silences these
cells (Sheard et al., 1972; Bramwell, 1974; Mosko and Jacobs, 1977).
Therefore, in general, the 5-HT system possesses a self-limiting
regulatory mechanism, i.e., an increase in 5-HT 'availability' leads
to a reduction of 5-HT cell firing activity.
Biochemical evidence had suggested that the indole hallucinogen,
LSD, decreases 5-HT cell firing activity (Aghajanian, 1972c).

Indeed,

this drug when applied systemically invariably inhibits 5-HT cell firing
(Aghajanian et al. , 1968).

Perhaps, LSD inhibits 5-HT cell firing by

stimulating 5-HT receptors.
Since 5-HT cell bodies are inhibited by iontophoretic appli¬
cation of the indole hallucinogens, as well as 5-HT (Haigler and
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Aghajanian, 1974a; Aghajanian and Haigler, 1975), it has been suggested
that an increase in 5-HT tone at 5-HT receptors within the dorsal raphe
could underlie this feedback regulation.

The concept of a local feed¬

back circuit has been supported by physiological studies.

Stimulation

of the 5-HT fibers emerging from the dorsal raphe initiates an anti¬
dromic action potential which invades the 5-HT cell bodies of the
dorsal raphe.

Antidromic stimulation of the 5-HT cells in this manner

markedly inhibits 5-HT cell firing during the post-stimulus period
(Wang and Aghajanian, 1977b).

These authors propose that antidromic

stimulation releases 5-HT from a network of collateral processes which
communicate among 5-HT cells.

In this way, increased 5-HT availability

at inhibitory 5-HT autoreceptors within the dorsal raphe may dampen
5-HT cell activity.
3. GABA-ergic Inhibition of 5-HT Cells
Examination of afferent pathways to the dorsal raphe has
produced evidence that GABA-ergic neurons exert a prominent inhibi¬
tory influence on the activity of 5-HT cells located there.

Appli¬

cation of the horseradish peroxidase retrograde tracing technique
to the dorsal raphe, demonstrated that the lateral habenula sends a
major projection to the dorsal raphe (Aghajanian and Wang, 1977).
Electrical stimulation of this pathway produced a pronounced inhibi¬
tion of 5-HT cell firing (Wang and Aghajanian, 1977c).

In an attempt

to identify the transmitter mediating this inhibtion, it was
found that systemic or iontophoretic application of picrotoxin, a
GABA antagonist, reduced the post-stimulus inhibitory period.

This

finding suggests that GABA-ergic neurons mediate the observed inhibition.
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GABA is implicated in the effects of a second afferent pathway.
Stimulation of the pontine reticular formation also inhibited 5-HT
cell activity (Wang et al., 1976).

Again, application of picrotoxin

but not strychnine, a glycine antagonist, blocked the inhibition.
These studies provide evidence that GABA plays an important role
in regulating 5-HT cell activity.

Experiments to be presented below

have examined the relationship of this GABA-ergic influence to the
NE regulation of 5-HT cell activity, discussed in the next section.
4.

NE-Regulation of 5-HT Neurons
The identification of 5-HT neurons in the dorsal raphe

by extracel1ular single unit recording techniques provided a more
direct approach to examining the functional activity of the 5-HT
system.

The ability to record from 5-HT neurons prompted several

studies which examined the effect of electrical stimulation of NE
systems on 5-HT cell activity in the dorsal raphe.

Stimulation of

the locus coeruleus NE system did not markedly affect 5-HT cell
firing (Wang et al., 1976; Anderson et al., 1977).

In order to

explore the possibility that the medullary NE system (Dahlstrom and
Fuxe, 1964) which projects to several brain stem areas was involved
in the regulation of 5-HT cell activity, stimulation of these cells
was also undertaken.

However, only weak and variable effects on

5-HT cell activity were obtained (Stern et al., 1980).

It is

interesting to note that amphetamine, which increases NE tone by
releasing NE (Glowinski and Axelord, 1965) does not markedly increase
baseline 5-HT cell firing activity either (Foote et al., 1969).
Therefore, these physiological studies suggest that an increase in
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NE tone does not affect 5-HT cell firing, whereas, the biochemical
studies with clonidine mentioned above, indicate that a decrease in
NE tone decreases 5-HT activity.

These apparently conflicting

observations can be interpreted as suggesting that under the condi¬
tions of these studies the NE system exerts a near maximal effect on
the 5-HT system; therefore further stimulation of the NE system
produces little effect, yet a reduction in NE tone could produce a
marked decrease in 5-HT cell activity.
Further physiological studies examined the effect of decreased
NE tone on 5-HT cell firing activity (Svensson et a 1., 1975).

These

studies demonstrated that low doses of clonidine which totally in¬
hibited the firing of NE cells in the locus coeruleus also suppressed
the firing of the overwhelming majority of 5-HT cells in the dorsal
raphe.

Clonidine's effect on 5-HT cells was attributed to an indirect

action mediated by its effect on NE systems, since local application
of clonidine in the vicinity of 5-HT cells did not produce an inhibi¬
tion of firing.

This finding implies that a decrease in NE tone

produces a parallel decrease in 5-HT cell activity.
vations support this interpretation.

Several obser¬

Administration of 6-OHDA intra-

ventricularly produced a suppression of 5-HT cell activity.

Admini¬

stration of alpha-methyl-para-tyrosine,an inhibitor of tyrosine
hydroxylase, slowed the firing of 5-HT cells.

Furthermore, the

suppression of firing produced by clonidine could be reversed by
amphetamine, which releases NE.
Further confirmation of this concept that decreased NE tone
decreases 5-HT cell activity came from studies with a variety of
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antipsychotic drugs.

Of several antipsychotic drugs tested only

some suppressed 5-HT cell activity (Gallager and Aghajanian, 1976a).
The alpha-adrenoceptor blocking potency of these drugs (Keller et
al .,

1973; Burki et al., 1975) was found to correlate with their

ability to suppress 5-HT cell

firing suggesting that blockade of

NE transmission produces a suppression of 5-HT cell

firing.

Further¬

more, since piperoxan, an alpha-adrenoceptor antagonist, but neither
sotalol, a beta-adrenoceptor antagonist, nor haloperidol, a dopamine
antagonist,

is effective in reducing 5-HT cell

firing,

it was sug¬

gested that an alpha-adrenoceptor mediates the NE regulation of 5-HT
cell

firing.
5.

Pharmacology of Central
While peripheral

Alpha-Adrenoceptors

alpha-adrenoceptors have been well

characterized pharmacologically (Furchgott, 1972), the difficulties
encountered in studying central
of central

al pha-adrenoceptors.

neurons have hindered the examination
Many of the classical

agonists and

antagonists do not readily enter the brain when applied systemically.
Furthermore, the effects of agents which do gain access to the brain
may not be the result of a direct interaction with the neuron under
study, since actions of the drug at distant sites may be relayed
afferent neuronal

pathways.

by

For these reasons, the microiontophoretic

application of drugs which allows their delivery to a limited area
enjoys important advantages.

This technique has been used extensively

in the studies presented below which examined the pharmacology of
the NE regulation of 5-HT neuronal

firing activity.

Evidence has recently accumulated for the existence of two
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different types of alpha-adrenoceptors; alpha-1 and alpha-2 adreno¬
ceptors (Langer, 1974; Starke et al., 1975).

The classical peripheral

post-synaptic alpha-adrenoceptor has been designated the alpha-1 adreno¬
ceptor, while the recently described 'pre-synaptic' alpha-adrenoceptor
which regulates the amount of transmitter released from NE terminals
has been classified as an alpha-2 adrenoceptor.

The pharmacological

differentiation of the two receptor types is based on the different rank
order potency of agonists, as well as the selectivity of antagonists.

For

example, while NE stimulates both alpha-1 and alpha-2 adrenoceptors,
alpha-methylnorepinephrine is more potent than NE at alpha-2 adrenoceptors
but less

potent at alpha-1 adrenoceptors.

In addition, antagonists have

been identified which show markedly different potencies at these two
receptors.

WB-4101, a potent alpha-1 receptor antagonist possesses little

activity at alpha-2 receptors while yohimbine exerts selective antagonism
at alpha-2 receptors (Kapur and Mottram, 1978; Drew, 1976, 1977;
Marshal 1 et al., 1978).
The presence of both alpha-1 and alpha-2 adrenceptors in brain has
been demonstrated by in vitro binding studies.

These studies have

demonstrated that clonidine, a potent alpha-2 agonist, and WB-4101, an
alpha-1 antagonist bind selectively to distinct alpha-adrenergic
sites (U'Prichard et al., 1977; U'Prichard and Snyder, 1979).
though alpha-2 adrenoceptors were originally described as

receptor

Even

pre-

synaptic in location, these studies have indicated that both alpha-1
and alpha-2 receptor types are located post-synaptically.

Therefore,

these receptor categories should be used only to refer to the pharmacology
of the receptor and not to their

anatomical

localization.
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The iontophoretic technique has been used to examine neuronal
responses to NE which are mediated by alpha-adrenoceptors.

Bevan

and co-workers (Bevan et al ., 1977; Szabadi, 1979) have examined the
response of unidentified cortical neurons to NE.

They found that

stimulation of alpha-adrenoceptors produces excitatory responses.
Their studies of the effects of several adrenergic agonists suggest
that these receptors can be classified in the alpha-1-adrenoceptor
category.

Rogawski and Aghajam'an (1980) have demonstrated on the

basis of extensive pharmacological studies that the activation of
lateral geniculate neurons by NE is mediated by alpha-1-adrenoceptors.
Cedarbaum and Aghajanian (1977) characterized pharmacologically the
inhibitory action of NE on NE neurons in the locus coeruleus.

The

rank order of the potencies of adrenergic agonists indicated that
NE's inhibitory action on locus coeruleus neurons
alpha-2-adrenoceptors.

is

mediated by

The pharmacology of the adrenoceptor mediating

NE's regulation of 5-HT cell firing will be examined in experiments
presented below (Experimental Studies, Section II).
IV.

Neuronal Organization of the Dorsal Raphe
1.

Non-Serotonergic Neurons of the Dorsal Raphe
Physiological experiments have demonstrated the presence

of both non-serotonergic neurons as well as 5-HT neurons in the
dorsal raphe.

A population of normally quiescent non-serotonergic

interneurons present in the dorsal raphe was

detected during a

study of the effect of stimulation of peripheral sensory nerves
on 5-HT cell firing.

While 5-HT cells were inhibited by peripheral

nerve stimulation, these neurons were transiently activated
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(Aahajanian et al., 1978).

The neurons which were activated by

peripheral nerve stimulation can be distinguished from the 5-HT
neurons with confidence since they are not activated antidromically
by stimulation of the ascending 5-HT fiber bundle.

Furthermore,

these interneurons were still activated by peripheral nerve stimu¬
lation following destruction of 5-HT neurons by 5,7-DHT pretreatment.
The presence of non-serotonergic neurons in the dorsal raphe
has also been suggested by anatomical experiments.
al.

Descarries et

3

(1979) have examined the dorsal raphe with H -5-HT autoradiography.

This technique selectively labels the serotonergic neurons present
in the dorsal raphe.

Of note, two-thirds of the neurons in the

3
dorsal raphe were not labelled by H -5-HT.

This finding confirms

the presence of non-serotonergic neurons in the dorsal raphe.
Several lines of evidence suggest that many of the non-serotonergic neurons present within the dorsal raphe are GABA-ergic.
The dorsal raphe contains one of the hiqhest levels of GABA and its
synthetic enzyme, glutamate decarboxylase, in brain (Tappaz et al.,
1979).

Kainic acid lesions of the dorsal raphe which are thought

to selectively damage cell bodies produced a marked decline in GABA
levels there indicating that the dorsal raphe contains intrinsic
GABA neurons (McGeer et al., 1979).

Anatomical evidence for the

presence of GABA-ergic neurons in the dorsal raphe has also been
provided by electron-microscopic autoradiographic studies with
tritiated GABA.

Following infusion into the ventricular system,

tritiated GABA is taken up by GABA neurons near the ventricular
surface which can be detected by autoradiography.

Examination of

16
sections of the dorsal raphe processed for electron-microscopic
autoradiography demonstrated that GABA-ergic neurons are present in
the dorsal raphe (Gamrani et al., 1980).

This combination of anato¬

mical and biochemical experiments suggest that GABA-ergic inter¬
neurons are located in the dorsal raphe.
These local GABA-ergic interneurons could mediate the inhibition
of 5-HT cells produced by stimulation of afferent pathways.

Ionto-

phoretic administration of picrotoxin in the vicinity of 5-HT cells
blocks the inhibition produced by stimulation of the lateral habenula
(Wang and Aghajanian, 1977c).

However, lesions of the lateral habenula

did not markedly reduce the concentration of GABA and glutamate decar¬
boxylase in the dorsal raphe (McGeer et al., 1979), indicating that
'long' GABA-ergic afferents from the habenula to the dorsal raphe do
not mediate this inhibition.

Alternatively, if local GABA neurons

were activated by habenular stimulation, this could produce the
picrotoxin sensitive inhibition of 5-HT cell firing, that was
described by Wang and Aghajanian (1977c).
Similarly, the inhibition of 5-HT cell firing produced by sti¬
mulation of ascending fibers is also blocked by picrotoxin (Wang et
al., 1976).

In addition, local interneurons in the dorsal raphe are

activated by sensory stimulation and display

a reciprocal firing

pattern to that of the 5-HT cells (Aghajanian et al ., 1 978).

These

observations are consistent with the proposal that local GABA-ergic
interneurons when activated by afferent stimulation, exert a prominent
inhibitory influence on 5-HT cell activity.
The dorsal raphe receives a prominent NE innervation which
has been demonstrated by histofluorescence (Fuxe, 1965), biochemical
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(Levitt and Moore, 1979) and immunocytochemical
Molliver, 1980) techniques.

(Grzanna a_nd

Experiments to be presented below

(Experimental Studies, sections I and II) suggest that this NE
innervation, as well as the GABA-ergic input, exerts a dramatic
control over 5-HT cell activity.
These experiments demonstrate

that reduction of NE transmission

within the dorsal raphe can totally suppress 5-HT cell firing
activity.

Since other afferent inhibitory influences on 5-HT cell

firing appear to be mediated by local GABA interneurons, NE might
exert its control over 5-HT cell firing in a similar fashion.

That

is.the reduction of inhibitory NE tone could allow normally quiescent
GABA-ergic interneurons within the dorsal raphe to fire.

These

activated cells could then, in turn, directly inhibit 5-HT cell
firing.

Alternatively, NE terminals might terminate directly on

5-HT cells; interruption of NE transmission could then block a
tonic NE activation of 5-HT cell firing producing the observed
cessation of firing.
Physiological experiments which will be presented below
(Experimental Studies, sections III) were aimed at determining
whether the NE regulation of 5-HT cells is mediated by local
GABA-ergic neurons or not.

As well, anatomical experiments

(Experimental Studies, section IV)

were conducted which were

aimed at determining whether 5-HT or non-5-HT neurons receive
the NE innervation in order to distinguish between the alternative
circuits which could underlie NE's action.
2.

The Origin of the NE Innervation of the Dorsal Raphe
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Prior to a discussion of the methods used to examine the
target of the NE innervation, it is of interest to consider its
origins.

Several studies have examined the possibility that NE

cells of the locus coeruleus project to the dorsal raphe.

While

an initial report suggested that the locus coeruleus innervates the
dorsal raphe (Loizu, 1969), recent studies involving more specific
lesions of the 1ocus coeruleus have not found either a decrease in
the density of fluorescent terminals or in NE levels in the dorsal
raphe (Levitt and Moore, 1979).

These findings argue strongly

against a locus coeruleus projection to the dorsal raphe.

In support

of these findings, retrograde tracing studies of the dorsal raphe
afferents labelled only occasional cells in the locus coeruleus
(Aghajanian and Wang, 1977).

Anterograde tracing studies of locus

coeruleus efferents also did not identify a projection to the dorsal
raphe (Jones and Moore, 1977).

Furthermore, lesions of the locus

coeruleus did not obviously decrease 5-HT cell firing (Gallager and
Aghajanian, 1976a) suggesting that the NE regulation of 5-HT cells
does not stem primarily from the locus coeruleus.

The other NE

cell nuclei are less compact than the locus coeruleus cluster and
therefore more difficult to manipulate experimentally.

However,

retrograde tracing of dorsal raphe afferents did reveal afferents
in the vicinity of the A1 and A2 cells in the medulla

(Aghajanian

and Wang, 1977), suggesting that medullary NE cells may contribute
to the NE innervation of the dorsal raphe.

Of note, evidence has

emerged recently from inmunocytochemical and autoradiographic
studies demonstrating the presence of an anterior portion of the
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locus coeruleus which extends into the midbrain central
(Grzanna et al., 1980; Nowaczyk et al., 1978).
these NE cells to the dorsal
considered a potential

grey

The proximity of

raphe requires that these cells be

source of the NE input to the dorsal

raphe.
3.

U1trastructural

Localization of NE

The visualization of NE terminals in the dorsal

raphe

by fluoresence histochemistry indicates presumed sites of transmitter
release.

However, because of the limited resolution of the light

microscope, electron microscopic methods were needed in order to
identify the neurons of the dorsal

raphe receiving the NE innervation.

The development of electron-microscopic autoradiography for
3
H -NE has allowed ultrastructural
elements.

identification of NE neuronal

Briefly, small amounts of tritiated NE, administered

intraventricularly, diffuse throughout the ventricular system and
into the brain parenchyma.

NE neurons which possess a high affinity

uptake system for NE (Iversen, 1971) can then selectively con3
centrate the H -NE.

The tissue is then fixed and processed for

autoradiography at both the light and electron-microscopic level.
This technique was first applied to the central

nervous system

by Aghajanian and Bloom (1966), who successfully visualized NE
terminals in the paraventricular nucleus by this method.

NE

terminals located there contained both small agranular and larger
granular vesicles similar to those described in peripheral
terminals (Grillo, 1966).

However,

NE

in contrast to peripheral

terminals which do not form classical

NE

synaptic junctions, central
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NE terminals were found to frequently participate in classical
synaptic junctions.
In more recent studies. Descarries and co-workers (Beaudet
and Descarries, 1978) have applied this method to cortical areas.
NE terminals and axons were successfully identified by this
technique.

In these studies, the selectivity of the labelling

was confirmed by two methods.

First, addition of non-tritiated

NE to the perfusate which should saturate the high-affinity NE
uptake system drastically reduced the labelling observed, as did
pretreatment of animals with 6-OHDA, the selective catecholamine
neurotoxin.

In view of its selectivity and widespread applicability,

NE EM-autoradiography provided a method by which NE terminals in the
dorsal raphe could be visualized in order to examine the nature of
the post-synaptic elements receiving the NE innervation.
V.

Scope of Experiments
Experimental studies were conducted which examined the nora¬

drenergic regulation of the 5-HT cells of the dorsal raphe.

First,

experiments were performed which indicated that reserpine, which
suppresses 5-HT cell firing (Aghajanian and Haigler, 1972) does
so by interfering with adrenergic transmission.

Furthermore, it

was found that NE, iontophoretically applied in the vicinity of
5-HT cells, reverses reserpine's suppression of 5-HT cell firing.
This finding suggests that the dense NE innervation of the dorsal
raphe regulates the activity of 5-HT cells located there.

Second,

the effect of a variety of adrenergic agonists and antagonists on
5-HT cell firing was examined in order to characterize the
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receptor mediating the NE control of 5-HT cell activity.

'Third,

since the studies outlined above indicated that NE released from
terminals in the dorsal raphe exerts a dramatic control over 5-HT
cell firing, the relationship of NE's regulation of 5-HT ceil
firing to the influence of GABA-ergic afferents to these cells
was

examined.

Finally, the synaptic circuitry underlying the

regulation of 5-HT cells by the NE innervation of the dorsal
raphe was investigated using the technigues of electron-microscopic
autoradiography.

METHODS
I.

Neurophysiological Techniques

1.

Introducin' on
In the four studies to be presented below both neuro¬

physiol ogical

and anatomical

first three experimenal

approaches have been used.

The

sections rely heavily on the physiological

techniques of single unit recording and microiontophoresis.
methods used in these experiments will

The

be described in this section.

Since 6-OHDA lesioned animals were used for some recording ex¬
periments the methods used in producing and evaluating the lesions
are described here as well.
the anatomical
which will
2.

The last experimental

section utilizes

techniques of electron-microscopic autoradiography

be described separately in the next section.
Single-Unit Recording
This section describes the methods used to record the

action potentials of individual

neurons by an electrode placed

extracel1ularly in the vicinity of the cell

body.

Single-barrel

glass micropipettes were pulled to a fine tip, broken back to a
diameter of less than 1 micron, and filled with a conducting
electrolyte solution of 2 M NaC1 , which was saturated with Fast
Green FCF (Fisher) dye.
were used fell

The impedances of the electrodes that

in the range of 3-6 Mft when measured at 60 Hz in

vitro.
Male Sprague-Dawley albino rats (Charles River) 200-300 g
were anesthetized with chloral

hydrate, 400 mg/kg i.p.; additional

injections were given as needed.

Rats were mounted in a stereo-
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taxic instrument; a burr hole was made over the raphe area whose
center was in the midline approximately 0.5 mm anterior to lambda.
Electrode signals were passed through a high-input impedance ampli¬
fier and monitored on an oscilloscope.

Integrated firing rate was

recorded in consecutive 10 sec samples from the rate meter.
body temperature was kept at 36-37°C.

The

Units displaying a character!'stic

slow firing rate (approximately 1 spike/sec), regular rhythm and
wide duration action potential (1-2 msec) typical of histochemically
and antidromically identified 5-HT cells were tested (Aghajanian
and Haigler, 1974; Wang and Aghajanian, 1977b).

Recording sites

were marked at the end of each experiment by passing 20 pA of
cathodal current through the recording barrel for 15 min, depositing
a green spot at the electrode tip (Thomas and Wilson, 1965).
were perfused with 1 0\ formalin.

Rats

The location of the electrode tip

was confirmed by histological examination to correspond to the
location of 5-HT-containing neurons in the dorsal raphe nucleus.
3.

Microiontophoresi s
In order to apply drugs to a limited area in the vicinity

of the recording electrode, the microiontophoretic technique, in
which drugs present in ionized form are ejected from micropipettes by
ionic currents was used (Curtis, 7964).

The amount of drug ejected

in this manner is approximately proportional to both the magnitude
of the applied current and the duration of the ejection period.

In

the interval in between drug ejections, a small retaining current,
usually 10 nanoamperes, of appropriate polarity was applied in order
to prevent diffusion of the drug out of the pipette.
Either double-barrel, 5-barrel or 6-barrel arrays of micropipettes
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were employed in order to combine a recording electrode with drug
delivery channels.

Double barrel electrodes were constructed from a

recording barrel prepared as described above and a second micropipette
broken back to a tip diameter of 2-5 urn.

The recording barrel was

positioned 15-30 ym ahead of the drug barrel and the two were cemented
together (Wang and Aghajanian, 1977a).

5-barrel micropipettes were

prepared in which a central barrel was fused with four surrounding
side barrels.

The 5-barrel assembly was then pulled to a fine tip,

and broken back slightly (Haigler and Aghajanian, 1974a).

In this

way, the central recording barrel and each of the side barrels were
separated by only a thin glass wall.

This arrangement allowed the

ejection of drugs in the immediate vicinity of the recording electrode.
Impedances were 3.5-4.5 Mr. in the central recording barrel.

The

drug solutions were directly injected into side barrels which contained
a few strands of fiberglass to allow rapid filling of tips by capillary
action (Tasaki et al., 1968).

The central recording barrel was filled

with 2 M NaCl solution saturated with Fast Green dye.
the balance channel, was filled with 4 M NaCl.

One side barrel,

This channel was used

to pass a current which was equal in magnitude to the sum of the cur¬
rents in the other channels, but of opposite polarity, in order to
eliminate any possible artefacts produced by net current flow away
from the micropipette assembly.

Circuits for drug ejection and cur¬

rent balance were similar to those described by Salmoiraghi and Weight
(1967), 6-barrel electrodes were constructed by positioning a singlebarrel recording electrode 20-30 ym ahead of a 5-barrel micropipette
that had been broken back to a tip diameter of 10-20 ^.m.
4.

Drugs
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The drugs administered during each of the first three sections
of the Experimental Studies are listed below.
a.

Section I
Reserpine powder (RES, Regis) for i.v. administration

and iontophoresis was dissolved by addition of a few drops of 10;.
phosphoric acid.
of NaOH solution.

The solution was titrated

to pH 4.2 by addition

The reserpine solution was freshly prepared for

each recording session.

Parachlorphenylalanine methylester HC1

(PCPA, Regis) 400 mg/kg i.p. was injected 40 hr prior to recording
experiments.
The following drugs were also administered systemically:
1-amphetamine sulfate (A); d-lysergic acid diethylamide bitartrate
(LSD); d , 1-p-chloroamphetamine hydrochloride (PCA, Regis); 1-nore¬
pinephrine bitartrate (NE, Regis); clonidine hydrochloride (CLON,
Boehringer Ingelheim).
The following drug solutions were prepared for microiontophoresis;
5-HT creatinine sulfate pH 5.0, 0.04 M (5-HT, Regis); 1-norepine¬
phrine bitartrate 0.1 M, pH 4.0 (NE); 1-alutamate monosodium pH 8.0,
0.1 M (G, Mann Labs).
b.

Section II
The following drugs were administered intravenously:

WB-4101

(2-21,6'-dimethoxy (phenoxyethylami no) methyl benzodioxan

HC1) (WB, WB Pharmaceuticals), piperoxane chlorhydrate (PIP, RhonePoulenc), thymoxamine HC1
HC1

(TMX, Wm. Warner, Ltd.), phenoxybenzamine

(PBZ, SK & F), dihydroergocryptine mesylate (DHK, Sandoz),

phentolamine mesylate (PHE, Ciba) d-lysergic acid diethylamide
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bitartrate (LSD), 1-amphetamine sulfate (A, Aldrich), reserpine
(RES, Regis).
Solutions for microiontophoresis were as follows:

WB (0.1 M)

pH 5.0; PIP (0.1 M) pH 4.0; TMX (0.1 M) pH 4.0; PBZ (2.5 mg/ml)
pH 3.6; DHK (3.0 mg/ml) pH 5.0; PHE (20 mg/ml) pH 5.5; serotonin
creatine sulfate (0.05 M) pH 5.0 (5-HT, Regis); 1-norepinephrine
bitartrate (0.1 M) pH 4.0 (Regis, NE); monosodium glutamate
(0.1 M) pH 8.0 (G, Mann labs); Sotalol HC1

(0.1 M) pH 4.0 (SOT,

Regis); 1 -isoproterenol-d-bitartrate (0.1 M) pH 4.0 (ISO, Regis);
1-phenylephrine HC1

(0.1 M) pH 4.0 (PE, Sigma); salbutamol sulfate

(0.1 M) pH 4.0 (SALB, Schering); 1-a-methylnorepinephrine (0.1 M)
pH 4.0 (a-MNE, Sterlinn-Winthrop).

The following drugs were also

used in ionically diluted solutions when iontophoresed from
5-barrel electrodes (section h of Results): WB- 4101
in 0.1

M NaCl , pH 5.0; glutamate (0.01 M) in 0.1
c.

(0.01 M)

M NaCl , pH 8.0.

Section III
The drug solutions used for microiontophoresis were

prepared as follows:

WB- 4101

(2- 2 ' ,6'- dimethoxy (phenoxyethyl ami no)

methyl benzodioxan HC1) 0.01 M in 0.1 M NaCl pH 5.0 (WB, WB
Pharmaceuticals); phentolamine mesylate 20 mg/ml pH 5.5 (PHE, Ciba)
1-norepinephrine-D-bitartrate, 0.1 M pH 4.0 (NE, Regis); 1-glutamate
monosodium, 0.1 M in 0.1 M NaCl, pH 8.0 (G, Mann Labs); y-aminobutryic acid, 0.1 M or 0.002 M in 0.1 M NaCl

(GABA, Calbiochem);

5-HT creatinine sulfate 0.05 M, pH 4.0 (5-HT, Sigma); glycine HC1,
0.1 M in 0.1 M NaCl, pH 4.0 (GLY, Sigma); strychnine, 10 mg/ml,
pH 4.0 (STR, Sigma); picrotoxin, saturated solution, pH 4.0 (PIC,
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K & K Laboratories); (+)N-methyl-bicucul1ine iodide, 10 mg/ml,
pH 4.0 (BIC, Pierce).
5.

Data Analysis
The ED50 of systemically administered drugs was determined

by log-probit analysis from the cumulative dose-response curves.
The IT50 which is a measure of the dose of iontophoretically applied
drugs required to produce a 50% depression of firing rate was
calculated as the product of I, the current in nanoamperes, and T50,
the time in seconds required to obtain a 50% depression (deMontigny
and Aghajanian, 1977).
6.

Intraventricular 6-hydroxydopamine Injections
In some rats, intraventricular injectionsof 6-0HDA, a

selective catecholamine neurotoxin (Malmfors and Thorenen, 1971)
were administered in order to damage central NE systems.

Twenty

minutes prior to intraventricular injections, animals were pre¬
treated with chiorimipramine, 20 mg/kg, i.p.

(Ciba) a 5-HT uptake

blocker, in order to decrease the possibility of accumulation of
6-0HDA into and subsequent damage of 5-HT neurons.

Rats were

anesthetized with chloral hydrate, 400 mg/kg, i.p., and mounted in
a stereotaxic apparatus.

6-OHDA (Regis) was prepared in concentra¬

tions of either 5 or 7.5 mg/ml

(free base) in a normal saline

solution, containing 1 mg/ml ascorbic acid.

Twenty microliters

of this solution, containing a total of either 100 or 150 yg of
6-OHDA was injected into the lateral ventricle according to the
technique described by Svensson et al. ( 1975).

Briefly, a 22 gauge

Hamilton syringe, containing the 6-OHDA solution was lowered into
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the brain through a burr hole placed just anterior to bregma and
approximately 1 mm lateral to the midline.

The syringe was lowered

approximately 2.5-3.5 mm below the dura.
Prior to injection, the placement of the tip in the lateral
ventricle was verified by aspirating a small amount of cerebrospinal
fluid into the syringe.

The injected animals were used for either

recording or histof1uorescence experiments 4-7 days later.
7.

Histof1uorescence
The formaldehyde-condensation histof1uorescence technique

for visualization of monoamines (Falck et a 1., 1962) was used to
determine the extent of damage produced by 6-OHDA injection.

Both

vehicle control and 6-OHDA pretreated animals were given the mono¬
amine oxidase inhibitor pargyline (Regis) 100 mg/kg, i.p., 7 hrs
before sacrifice, in order to increase the brain levels of mono¬
amines.

Following chloral hydrate anesthesia,

animals were de¬

capitated and the brains processed for histofluorescence by the
Falck-Hillarp procedure (Falck et al., 1962).

Briefly,frontal

slabs of brain tissue were frozen rapidly by immersion in a propanepropylene oxide mixture cooled by liquid nitrogen.

The tissue

pieces were freeze-dried at -35°C for 4 days, and then exposed to
formaldehyde vapors in a sealed chamber.

Following embedding of

the tissue pieces in paraffin, 10 micron sections were examined by
fluorescence microscopy.
11.

Electron-Microscopic Autoradiography
1 .

Overview
An overview of the autoradiographic method for identifying
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NE or 5-HT neuronal processes is presented here prior to the more
detailed description given below.

Small amounts of either tritiated

NE or 5-HT were placed in the cerebrospinal fluid by intraventricular
injection.

Following diffusion into the brain parenchyma, the

tritiated compound was selectively accumulated by neuronal processes
which possess high-affinity uptake systems for the substance.

The

animal was then perfused with fixative which 'binds' the labelled
compound in situ to the tissue preventing its removal by solvents
during further processing of the tissue.

Tissue sections for

either light or electron microscopy were then cut, placed on
slides and coated with photographic emulsion.

In the process of

autoradiography, the beta particles emitted by the tritium result
in the production of silver photographic grains.

The grains are

opaque and electron dense and when developed can be visualized by
either light or electron-microscopy.
The combination of Ilford emulsion (with photographic crystals
1000-1600 A in size) and thin sections of tissue (< 1000 A) permits
a theoretical distance between the location of the beta emitter
bound to the tissue, and the position of the developed grains of
about 1850 A
2.

(Bachman and Salpeter, 1965).

Intraventricular Injections of Tritiated NE or 5-HT
Male albino rats (Charles River, Inc.) weighing 225-275 g

were used.

Just prior to injection with tritiated NE or 5-HT, the

rats (n=16) were pretreated with the monoamine oxidase inhibitor,
pargyline, 100 mg/kg, i.p., to prevent the breakdown of these amines. Fluox¬
etine, a specific 5-HT uptake inhibitor (Wong et al., 1975) 10 mg/kg.
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i.p. was also given at this time to rats receiving
to prevent uptake of

3

H-NE into 5-HT neurons.

H-NE in order

Alternatively,

desipramine (25 mg/kg, i.p.), a NE uptake blocker (Glowinski and Axelrod,
3
1964) was given to rats receiving

H-5-HT.

Rats were anesthetized with chloral hydrate (400 mg/kg, i.p.)
and placed in a stereotaxic apparatus.

Two hundred uCi of either

tritiated NE or 5-HT was injected (25-43 Ci/mM New England Nuclear
or Amersham) intraventricularly, according to the method described
by Svensson et al.

(1975) in volume of 50 microliters at a rate

of 1 microliter per minute.

Prior to use, the purity (> 90c) of

the tritiated compounds was confirmed by thin layer chromatography.
Ninety minutes following completion of the injection, the rats
were perfused transcardially first with a 4% dextran-saline flush
and then for 1 hour with cold fixative consisting of paraformaldehyde (lib), gl utaral dehyde (2%) (Fisher) in 0.15 M sodium phosphate
buffer (0.1 M, pH 7.2).

Tannic acid

(2%)

(Fisher) was included as

a mordant to improve final contrast.
In some cases, rats receiving tritiated NE had been pretreated
48 or 72 hours earlier with an intraventricular injection of 5,7dihydroxytryptamine (5,7-DHT) or 6-hydroxydopamine (6-OHDA) res¬
pectively.

Rats given intraventricular injections of the cate¬

cholamine neurotoxin, 6-OHDA (100 pg, free base) were pretreated
with chlorimipramine, 20 mg/kg, i.p. twenty minutes prior to the
intraventricular injection in order to protect 5-HT neurons.

Prior

to intraventricular injection of the selective serotonin neuro¬
toxin, 5,7-DHT (200 pg, free base), the animals were pretreated
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with DM I 25 mg/kg, i.p.

This treatment has been shown to enhance

the selectivity of 5,7-DHT's action (Bjorklund et al., 1975).

Previous

studies have shown that this procedure selectively destroys the 5-HT
neurons throughout the dorsal raphe (Aghajanian et al., 1978).
3.

Preparation of Tissue for Microscopy and Autoradiography
Following perfusion, brains were removed and frontal

slabs through the area of the dorsal raphe nucleus were blocked
and wahsed 30 minutes in phosphate buffer.

Blocks were then

immersed in 1% cold osmium tetroxide in phosphate buffer for 2
hours, washed overnight in phosphate buffer, rinsed in 0.1 M
sodium acetate (pH 7.2) and stained en bloc with cold IT uranyl
acetate for 2 hours.

Blocks were then rewashed in sodium acetate,

dehydrated, and embedded in Maraglas.
Liqht autoradiography was carried out on thick sections (2 y)
using Ilford G-5 emulsion and D-19 (Kodak) developer.

Electron-

microscopic autoradiography was performed on thick (silver to pale
gold) sections.
slides

The thin sections were placed on celloidin coated

2% in amyl acetate) by the loop method.

{

They were then

lead-citrate stained, carbon-coated in a vacuum evaporator, dipped
in Ilford L-4 emulsion at a dilution prechecked to give a monolayer
of silver halide crystals and exposed in the dark for 1-6 months.
Phenidone A (Ciba-Geigy) fine grain developer was used.

After

development, the celloidin membranes were floated onto a clean
surface of water and 200 mesh copper grids were placed over the
sections.

The membranes were picked up on filter paper discs using

a suction device.

After drying, the grids were lifted from the
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membrane and the celloidin was thinned by dipping in amyl acetate.
Sections were examined in a Zeiss EM9S electron microscope.
Tissue from one group of animals (n=5) was processed for
glyoxylic acid-induced histof1uoresence as described by de la
Torre (1979), in order to monitor the adequacy of depletion of NE
terminals induced by 6-OHDA.

Another group (n=6) were processed

for formaldehyde-induced histofluorescence to confirm the degenera¬
tion of 5-HT cell bodies following 5,7-DHT treatment.
4.

Data Analysis
The density of labelled terminals was determined by the

following method.

Sections were developed at regular intervals

until clusters of 7 or more developed grains were observed.

In

successive weeks, the number of clusters observed per grid square
was monitored until a plateau level was reached, suggesting that
a saturation of NE-labelled terminals had occurred.

The number of

grains per grid square (2,025 square microns) was determined in
sections developed during this plateau phase.

EXPERIMENTAL STUDIES
I.

Reserpine Suppression of Dorsal Raphe Neuronal

Firing: Reversal

by Local NE Iontophoresis
1 .

Background
The activity of the serotonin (5-HT)-containing cells

of the nucleus raphe dorsalis is sensitive to both serotonergic
and adrenergic influences.

Increased levels of 5-HT produced

either by tryptophan loading or monoamine oxidase inhibition
decreases their firing rate (Aghajanian et al. , 1970; Trulson and
Jacobs, 1975; Gallager and Aghajanian, 1976c).

Inhibition of 5-HT

reuptake also diminishes the activity of 5-HT cells (Sheard et
al. , 1972 ; Bramwell, 1974 ; Mosko and Jacobs, 1977; Gallager and
Aghajanian, 1975).

These findings have suggested the concept

that 5-HT cell activity is inversely related to 5-HT "availability"
(Aghajanian, 1972b).
Pharmacological evidence also suggests the presence of an
adrenergic influence on the dorsal raphe.

Reduction of adrenergic

tone either by blockade of postsynaptic a-receptors, inhibition
of catecholamine synthesis, or cessation of adrenergic neuronal
firing leads to a depression of 5-HT cell firing (Svensson et al.,
1975; Gallager and Aghajanian, 1976a).

Furthermore, the ampheta¬

mines, which release catecholamines (Glowinski and Axelord, 1965;
Stein and Wise, 1969; Carr and Moore, 1970), reverse this
suppression.
Reserpine suppresses the firing of 5-HT neurons in the dorsal
raphe (Aghajanian and Haigler, 1972).
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Since reserpine markedly
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depletes brain concentrations of both 5-HT (Brodie et al., 1955)
and catecholamines, (Holzbauer and Vogt, 1956; Bertler et al.,
1956) either of these actions might be responsible for the effect
of reserpine on raphe activity.

By disrupting the normal storage

mechanisms, reserpine could cause an overflow of 5-HT.

This in¬

creased availability of 5-HT might then produce the depression of
raphe cell firing.

Alternatively, reserpine's action could stem

from its interactions with the adrenergic system.

By interfering

with adrenergic transmission reserpine could secondarily cause a
depression in 5-HT cell firing.
In an attempt to further elucidate the role of serotonergic
and adrenergic influences on the dorsal nucleus, experiments aimed
at defining the mechanisms underlying reserpine's action on 5-HT
cell activity were conducted.
2.

Results
a.

Time Course of Effects of I.V. Administered Reserpine
on 5-HT Cell Activity
The i.v. administration of reserpine, 5 mg/kg, usually

caused an initial transient increase in firing rate.

Within 20-

30 min, this was succeeded in all cells by a marked depression of
firing rate (n=23).

Recovery to normal firing pattern was

gradual, beginning at 18-24 h and approaching completion between
24-48 h, in all 8 animals studied.
b.

Microiontophoresis of Reserpine
The iontophoretic application of reserpine (10 nA,

4-10 min) gradually depressed firing rate by an average of 153
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Fi gure 1 :
Suppression of 5-HT cell firing by reserpine: reversal by
1-amphetamine, blockade by intraventricular 6-OHDA injection.
In control animals (top trace) i.v. injection of 5 mg/kg reserpine
suppresses firing within 30 min.

1-Amphetamine (A) i.v. 0.5 mg/kg

completely reverses reserpine effect.

5 days after intraventricular

injection of 6-OHDA (100 ugh reserpine's depressant effect is
blocked (bottom trace).

*-0£

SPIKES PER 10 SECONDS

■
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(n=9).

It did not alter the rapid inhibition of cells produced by

iontophoretically applied 5-HT (Aghajanian et al., 1972b).
c.

6-OHDA Lesions: Effects on the Reserpine Induced
Depression of 5-HT Cells
To ascertain the role of the adrenergic system in

reserpine's action, the effect of reserpine was tested in animals
pretreated with intraventricular injections of 6-OHDA (Ungerstedt,
1971).

Consistent with a reduction of adrenergic tone, Svenssori

et al. (1975) reported an erratic and abnormally slow firing
pattern of the 5-HT cells for two days following injection.

How¬

ever, in animals tested 4-7 days after injection, the rate and
pattern of firing of cells was indistinguishable from that in
untreated animals, suggesting that 5-HT cells may adapt to a
severely compromised adrenergic system.

During this period,

reserpine's usual depressant effect was prevented in all 4 or
the animals receiving 150 eg (free base) and in 9 out of 10
animals receiving 100 eg (Fig. 1).

Examination of tissue sections

processed for histof1uoresence revealed, inter alia, a loss of
catecholamine fluorescence in terminals near the dorsal raphe;
5-HT fluoresence in 6-OHDA pretreated animals did not differ
from controls injected only with the ascorbic acid vehicle.
d.

Reversal of Depressant Effect of Reserpine on
5-HT Cells
If reserpine's effect is mediated by its interaction

with the adrenergic system, then restoration of adrenergic tone
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should reverse reserpine's depressant effect.

Amphetamine is

capable of releasing NE following reserpine administration (Kalisker
et al ., 1975).

Indeed, small

promptly restored 5-HT cell

doses of 1-amphetamine (0.5 mg/kg)

firing (n=6).

In addition, clonidine

which at high doses is a directly acting central
a-agonist (200-400 yg)

(Anden et al., 1970)

reserpine's action (n=5)
Since clonidine,
peripheral

postsynaptic

sharply reversed

(fig. 2).

in this dose range, has a direct action on

post-synaptic a-receptors

(Kobinger and Walland, 1967;

Boissier et al., 1968; Rand and Wilson, 1968) control

experiments

were performed to determine the effect on raphe firing of the
increase in blood pressure produced by its potent, vasoconstrictive
action.

Following reserpine administration, NE in doses up to 15

yg/kg (n=3)
a peripheral

i.v. did not affect the firing rate,

indicating that

a-adrenergic action is not sufficient to account for

the restoration of raphe firing produced by amphetamine and cloni¬
dine.
e.

Effect of NE Iontophoresis on 5-HT Cell

Firing

In an attempt to determine whether the effects of
adrenergic drugs could be related to catecholamine terminals
present in the vicinity of the 5-HT neurons, the effect of iontophoretically applied NE on raphe cells was tested.

In untreated

animals, the effect produced by iontophoresis of NE from doublebarrel electrodes on 5-HT cell

firing varied with firing rate.

Of 30 cells tested, with currents in the range of 5-15 nA, threefifths showed no change in firing rate, one-fifth showed moderate
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Figure 2:
Reversal of reserpine's depressant effect by 1-amphetamine
or clonidine; inability of 1-amphetamine to reverse PCA.
Reserpine 5 mg/kg, i.v. was administered 15 min prior to time
indicated by arrowhead.

Both 1-amphetamine 0.5 mg/kg and

clonidine 200 yg/kg reverse reserpine's inhibition of firing.
The inability of i.v. NE (15 yg/kg) to achieve reversal is
demonstrated in middle trace.

The same cell is then inhibited

by the usual dose of LSD (10 yg/kg).

The inhibition of 5-HT

cells produced by PCA (0.75 mg/kg) is not reversed by 1.5 mg/kg
of A (bottom trace).

15 minutes
after RES

15 minutes
after RES

SPIKES PER 10 SECONDS

J

JL-JUJLNT.

PC A

5 MIN
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increases of less than 50% in rate, while the remaining fifth all
of which had the slowest firing rates

(0.1-0.4 spikes/sec) had

sharp increases more than doubling their rate.

However, following

the systemic administration of reserpine,1ow currents of NE 2-10 nA,
dramatically reversed the profoundly depressed firing rate in all
cells

(n=16) regardless of original

baseline rate (fig.

LSD (10-20 pg) administered i.v.
cells.

3).

inhibits the firing of 5-HT

Since this action is not readily reversed by amphetamine

(Foote et al., 1969) or blocked by intraventricular injections of
6-0HDA (Svensson et al., 1975; Gallager and Aghajanian,

1976a),

it

is unlikely that any possible interactions of LSD with adrenergic
systems contribute significantly to its ability to inhibit 5-HT
cell

firing.

Thus, the inability of iontophoretically administered

NE to reverse the depression of 5-HT cells produced by LSD, while
glutamate retains its excitatory action (n=5)

(fig.

3), argues against

the possibility that general excitatory effects of NE, are res¬
ponsible for its reversal

of reserpine's suppression of 5-HT cell

firing.
f.

Lack of Effect of PCPA Pretreatment on Reserpine
Induced Depression of 5-HT Cells
Reserpine's action might stem from its interaction

with 5-HT neurons.

By disrupting the storage mechanism of 5-HT,

it could increase the availability of 5-HT which could then
depress the firing of 5-HT cells.

However, PCPA, a potent, specific

inhibitor of tryptophan hydroxylase which depletes 5-HT (Koe and
Weissman, 1966; Jequier et al., 1967) did not alter the effects
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Figure 3:
Local

iontophoresis of NE reverses inhibition of 5-HT cell

activity produced by reserpine but not LSD.
was given i.v.

Reserpine (5 mg/kg)

10 min prior to time indicated by arrowhead (top

trace).

6 nA of NE applied iontophoretically reverses reserpine's

effect.

In bottom trace, iontophoretically applied 5-HT (20 nA)

rapidly and reversibly inhibits 5-HT cell
has little effect on firing.
firing.

firing while NE (10 nA)

LSD (15 ug/kg) i.v.

inhibits

10 nA of NE which reverses depressed firing rate produced

by reserpine,

is ineffective in reversing LSD-induced inhibition.

However, pulses of glutamate (10 nA, G) still

excite the cell

demonstrating its continued presence in the recording field of
the electrode.

NE
_6

10 minutes
after RES

SPIKES PER 10 SECONDS

5HT
22

NE
JO

5 MIN

G

NE
_6

G G
NE

G
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of reserpine administration (n=6) or its reversal

by 1-amphetamine

(n=2).
g.

PCA Depression of 5-HT Cell

Firing Not Reversed By

1-Amphetamine
I.v. administration of parachloramphetamine, PCA inhibits
raphe cell

firing (Sheard, 1974; Mosko and Jacobs, 1977) probably

through its ability both to release 5-HT and inhibit it's reuptake
(Sanders-Bush et al., 1974).

If reserpine were acting in a similar

manner, then we would expect similar responses to amphetamine admini¬
stration.

Yet 1-amphetamine (1-2 mg/kg)

in contrast to its abrupt

reversal of the reserpine-induced cessation of firing, did not
reverse PCA induced depression of firing (n=6)
3.

(Fig. 2).

Piscussion
The results of this section suggest that reserpine's

suppression of firing of raphe neurons is mediated through its
effect on the adrenergic system.

The ability of the catecholamine

terminal destruction produced by the specific neurotoxin, 6-OHDA,
to prevent reserpine's effect argues strongly that reserpine's
interaction with the adrenergic input underlies the depression of
activity witnessed.

Furthermore,

in non-lesioned animals, the

effect of reserpine can be reversed by the restoration of
adrenergic tone.

Evidence has been accumulating that 1- and d-

amphetamine are nearly equipotent in affecting the function of
NE neurons, while the d-isomer of amphetamine is much more potent
than the 1-isomer in its effect of dopamine neurons (Svensson,
1971; Ferris et al ., 1972; Harris and Baldessarini, 1973; Thornburg
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and Moore, 1973; Bunney et al., 1975; Holmes and Rutledge,^ 1976).
Therefore, the 1-isomer was administered because of its more selec¬
tive action on NE neurons.

Small doses of 1-amphetamine caused a

dramatic, prompt reinstatement of 5-HT cell activity which had
been depressed by reserpine.

The administration of a post-synaptic

a-agonist, clonidine, achieved a similar effect.
These results are consistent with those observed following a
reduction of adrenergic activity produced in other ways.

Extensive

destruction of the adrenergic system produced by 6-OHDA slows 5-HT
cells for several days.

In addition, the inhibition of adrenergic

neuronal firing caused by low doses of clonidine silences 5-HT
cell activity.

Furthermore, clonidine's inhibitory action on 5-HT

cells is analogous to reserpine's in being prevented by 6-OHDA and
reversed by amphetamine, as well as by higher doses of clonidine
itself (Svensson et al., 1975).
Reserpine has been shown directly to block adrenergic trans¬
mission in the peripheral autonomic system (Von Euler, 1969:
Sedvall and Thomson, 1965).

This may be the result of depletion

of a small functional NE pool directly involved in transmission
(Haggendal and Lindqvist, 1964).

Thus, blockade of adrenergic

transmission by reserpine could account for the silencing of
raphe cell firing.
On the other hand, certain behavioral effects of reserpine
have been proposed to stem from its ability to "release" 5-HT,
resulting presumably from interference with the normal storage
mechanisms (Shore et al., 1957).

Conceivably, this increased
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availability of 5-HT might then explain the depression of -5-HT
cell activity observed.

However, several studies have suggested

that transmitter synthesized during this time is subjected to
intraneuronal degradation (Kopin and Gordon, 1962, 1963; Stjarne,
1 964; Iversen et al., 1965; Glowinski et a 1., 1 966).

In addition,

the fact that a blockade of 5-HT synthesis by PCPA failed to alter
reserpine's action does not support the view that reserpine's
questionable ability to release 5-HT extracel1ularly mediates its
suppression of 5-HT cell firing.

However, since PCPA does not

deplete 5-HT entirely from cell bodies in the dorsal raphe
(Aghajanian et al., 1973) we cannot exclude serotonergic involve¬
ment in reserpine's action on this basis.

Therefore, additional

evidence was sought by experiments employing PCA.
which releases 5-HT, inhibits 5-HT cell firing.

This compound,
Its depressant

action on raphe units is effectively blocked by PCPA pretreatment
(Mosko and Jacobs, 1977).

This strongly suggests that the inhibition

of 5-HT cells produced by PCA, stems from its ability to increase
5-HT "availability".

If indeed, reserpine were acting in a similar

fashion, we would predict that PCA's inhibition of raphe firing
would be reversed by 1-amphetamine.

This was not the case.

Perhaps the most surprising result presented above is the
ability of locally iontophoresed NE to reverse reserpine's depression
of raphe firing.

The presence of a dense catecholamine innervation

of the dorsal raphe has been established by biochemical, histofluoresence, and immunocytochemical techniques (Fuxe, 1965;
Roizen and Jacobwitz, 1976; Swanson and Hartman, 1975).

The

ability of local NE iontophoresis to mimic the actions of
amphetamine and clonidine in reversing reserpine's inhibition of
single unit activity suggests the possibility that these terminals
provide the anatomical basis of the adrenergic drug effects ob¬
served on the 5-HT cells of the dorsal raphe.
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11.

Suppression of Firing Activity of 5-HT Neurons in the Dorsal
Raphe by ATpha-Adrenoceptor Antagonists
1.

Background
Pharmacological evidence suggests that the firing activity

of serotonin-containing (5-HT) cells of the dorsal raphe nucleus is
dependent on a tonically active adrenergic system.

Administration

of either a low dose of clonidine (Svensson et al., 1975), which
acts presynaptically to inhibit norepinephrine (NE) cell firing,
or reserpine, which impairs noradrenergic transmission, suppresses
5-HT cell firing (Section I of Experiments).

Furthermore, amphetamine,

which releases catecholamines (Glowinski and Axelrod, 1965; Stein
and Weiss, 1969; Carr and Moore, 1970) rapidly restores firing
after either of these treatments.
Antipsychotic drugs which are thought to possess adrenergic
blocking activity (Keller et al., 1973) reduce 5-HT cell firing
when administered systemically (Gallager and Aghajanian, 1976a).
An alpha-adrenoceptor is thought to mediate these effects since
piperoxane, an a-antagonist, but neither sotalol, a 6-adrenoceptor
antagonist, nor haloperidol, a dopamine antagonist, is effective
in reducing 5-HT cell firing (Gallager and Aghajanian, 1976a).
In addition, clonidine which in high doses acts centrally as a
postsynaptic alpha agonist (Anden et al., 1970), can restore
activity after the suppression of firing produced by either
reserpine or small doses of clonidine (Svensson et al. , 1975).
The dorsal raphe receives a prominent adrenergic input as
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demonstrated by histofluorescence (Fuxe, 1965), biochemica-1
(Roizen and Jacobowitz, 1976) and histochemical techniques
(Swanson and Hartman, 1975).

Thus, the adrenergic terminals

mediating the adrenergic-serotonergic interaction could be
located in the dorsal raphe itself.

This suggestion is supported

by the ability of NE to reverse the reduction of firing produced
by reserpine when NE is applied iontophoretically in the vicinity
of 5-HT cells (Section I of Experiments).
To determine whether alpha-adrenoceptor blockers, in general,
can suppress 5-HT cell firing, several different types of alphaadrenoceptor antagonists were tested in the present study.

These

agents represent a variety of chemical classes: a haloalkylamine,
phenoxybenzamine (Nickerson and Nomaguchi, 1951), an ergot alkaloid,
dihydroergocryptine (Rothlin, 1946), an imidazoline, phentolamine
(Meier and Yonkman, 1949), two benzodioxans, WB-4101 and piperoxan
(Mottram and Kapur, 1975; Bacq and Fredericq, 1934), and a thymoxyalkylamine, thymoxamine (Greeff and Schumann, 1953).

The effects

of these drugs on 5-HT cell firing were determined after their
systemic administration.

Furthermore, in the light of the

possibility that alpha-adrenoceptor antagonists block the effects
of NE released from adrenergic terminals located within the dorsal
raphe, the effects of the local, iontophoretic application of
these drugs on single unit activity of 5-HT cells in the dorsal
raphe were also investigated.
2.

Results
a.

Effects of Systemic Administration of Alpha-
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Adrenoceptor Antagonists on 5-HT Cell Activity
Intravenous administration of the alpha-adrenoceptor
antagonists WB-4101

(n=27), piperoxan (n=8) or thymoxamine (n=9)

rapidly and totally suppressed 5-HT cell firing.

The ED50 for

suppression of firing for these drugs was as follows:

WB-4101,

41 + 20 pg/kg (ED50 +_ SD); piperoxan 0.64 + 0.20 mg/kg; thymoxa¬
mine, 0.42 +0.31 mg/kg.

Phenoxybenzamine (3.0 mg/kg, n=6) also

suppressed firing but this occurred gradually over 30 min (fig. 4).
In animals tested after previous injections of PBZ (25 mg/kg, i.p.),
recovery of activity had commenced by 15 hr (n=4) and gradually
neared completion at 36 hr (n=3).

In contrast to the above drugs,

large doses of dihydroergocryptine (6.0 mg/kg, i.v. n=4) only
partially suppressed firing (10-504).

Phentolamine, at doses up

to 10.0 mg/kg (i.v.) (n=4) did not suppress firing rate by more
than 20%.

Perhaps the weak activity of these two drugs when given

by the systemic route stems from their limited ability to enter
the brain (see Discussion).
b.

Effects of 6-OHDA Lesions on WB-4101 Suppression of
5-HT Cell Firing
The destruction of adrenergic terminals by 6-0HDA

has been shown to block the ability of the pre-synaptically
acting drugs, reserpine and low doses of clonidine (Section I of
Experiments) (Svensson et al., 1975) to suppress the firing
activity of 5-HT cells.

Therefore, the effect of 6-OHDA pretreat¬

ment on the ability of an alpha-adrenoceptor antagonist,
to suppress 5-HT cell firing was examined.

WB-4101,

Animals were given
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Figure 4:
Suppression of 5-HT cell firing by al pha-adrenoceptor anta¬
gonists: reversal of competitive blockade by 1-amphetamine.
Intravenous administration of WB-4101

(WB: successive doses of

30, 15, 15 ug/kg given at times indicated by arrows), piperoxan
(PIP: 1 mg/kg), or thymoxamine (TMX: 1.5 mg/kg) rapidly suppressed
firing.

Phenoxybenzamine (PBZ: 3.0 mg/kg, i.v.) gradually suppressed

firing within 30 min.

1-Amphetamine (1-A: cumulative doses of

2 mg/kg, i.v.) restored activity following suppression of firing
caused by the three competitive antagonists.

However, 1-A (5 mg/kg,

i.v.) was ineffective in overcoming the non-equilibrium blockade
produced by phenoxybenzamine.

The ability of LSD (10-15 pg/kg, i.v.)

to inhibit 5-HT cell firing remained unimpaired.
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intraventricular injections of 6-OHDA (150 ug, free base).

For

the first few days, 5-HT cells fired slowly and erratically,
consistent with the loss of adrenergic tone.

However, in animals

tested 4-7 days after injection, the normal rate and pattern of
firing resumed (Svensson et al., 1975), suggesting that 5-HT cells
may adapt in some manner to a severely compromised adrenergic
system.

During this period, the ability of WB-4101 to suppress

firing activity was tested.

The ED50 for suppression of firing

by WB-4101 was found to be 91 + 45 ug/kg (ED50 + SD) (n=9).
This value was significantly greater than that obtained in unlesioned animals, 41 +20 ug/kg (p<0.02).
c.

Effect of 1-Amphetamine on Suppression of 5-HT
Cell Firing Produced by Alpha-Adrenoceptor Antagonists
As the administration of a variety of alpha-adreno-

ceptor antagonists suppressed 5-HT cell firing, it was of interest
to observe the effects of an increase in adrenergic tone produced
by amphetamine on this suppression.

Evidence has been accumulating

that 1- and d-amphetamine are nearly equipotent in affecting the
function of NE neurons, while the 1-isomer of amphetamine is much
less potent than the d-isomer in its action on dopaminergic neurons
(Svensson, 1971; Ferris et al ., 1972 ; Harris and Baldessarini, 1973;
Thornburg and Moore, 1973; Bunney et al., 1975; Holmes and Rutledge,
1976).

Therefore, the 1-isomer was selected for use because of its

more selective action on NE neurons.

First, doses of WB-4101 or

thymoxamine causing greater than 80% suppression of firing were
administered.

Following the administration of WB-4101, 1-amphetamine
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(2.0-5.0 mg/kg, i.v.) was administered.

When 1-amphetamine was

given during a period of total suppression of firing, it restored
activity in only 2 out of 5 animals, suggesting that the limited
catecholamine supply released by amphetamine might be unable always
to overcome the high degree of competitive blockade produced by
WB-4101.

However, when 1-amphetamine was given after recovery to

a low level of firing, it consistently restored cell firing close
to baseline rate (n=5).

Following thymoxamine administration,

1-amphetamine was always able to restore firing (n=5).

As pre¬

viously reported (Gallager and Aghajanian, 1976a), 1-amphetamine
also restored activity when administered during the suppression
of firing caused by piperoxan (n=3).

If the NE releasing action

of amphetamine does underly the observed restoration of firing
activity, then amphetamine might be effective only during the
suppression of 5-HT cell firing produced by competitive antagonists.
Therefore, the response to 1-amphetamine was examined when admini¬
stered following phenoxybenzamine, which produces a non-equili¬
brium blockade (Nickerson, 1957).

After phenoxybenzamine, doses

of 1-amphetamine up to 5.0 mg/kg (n=4) were ineffective in restoring
activity (fig. 4).
d.

Effect of NE Iontophoresis on 5-HT Cell Firing
Previous studies have examined the effect of NE

iontophoresis on the spontaneous firing activity of 5-HT cells
(Svensson et al., 1975; Gallager and Aghajanian, 1976a; Aghajanian
et al ., 1972b;Couch, 1970; Haigler and Aghajanian, 1973).
investigators, using 5-barrel electrodes, reported variable

These

effects in the dorsal raphe.

These observations differ from the

absence of depressant responses noted when NE is iontophoresed from
2- or 6-barrel electrodes in which the drug ejection barrel is
separated by 20-30 pfrom the recording electrode (Section I of
Experiments).

This difference between the effect of NE when ion-

tophoresed in the vicinity of the soma with 5-barrel electrodes
and when applied at a distance with 6-barrel electrodes suggests
that the depressant response observed with the former may be re¬
lated to high concentrations of NE deposited close to the cell
body.

Therefore, a more detailed investigation of NE's effect was

undertaken in the present study.

When low currents of NE were

tested from 5-barrel electrodes, activation of 5-HT cell firing
prevailed; however, at higher currents an increasing proportion
of depressant responses was observed (Table 1).
e.

Reversal of Effects of Competitive Alpha-Adreno¬
ceptor Blockade by NE Iontophoresis
Following systemic administration of several com¬

petitive alpha-adrenoceptor blocking agents, the ability of NE
iontophoresis to restore firing activity was tested.

Six-barrel

electrodes were used in order to avoid the direct depressant effects
of NE, which occur with 5-barrel electrodes.

As illustrated in

Figure 5, the iontophoresis of NE (<_ 15 nA) reversed the diminished
activity caused by the competitive alpha-adrenoceptor blocking
agents, WB-4101 (7 of 8 trials), piperoxane (3 of 4 trials), and
thymoxamine (5 of 5 trials).

In contrast, following phenoxybenzamine,

which produced a non-equilibrium blockade, NE, at currents up to
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Figure 5:
Reversal by NE iontophoresis of suppression of 5-HT cell
firing produced by systemic administration of alpha-adrenoceptor
antagonists.

Intravenous administration of the competitive

antagonist WB-4101

(two doses of 25 ug/kg) piperoxan (3 doses

of 0.4 mg/kg) or thymoxamine (0.8 mg/kg) caused a reduction of
firing rate.

Iontophoresis of NE in the vicinity of 5-HT cells

promptly restored activity.

As shown in the top panel, the

inhibitory action of LSD (10 ug/kg) was unaffected by NE ionto¬
phoresis.

Pulses of glutamate (G) elicited spikes demonstrating

the continued presence of the 5-HT cell in the recording field.

SPIKES PER 10 SECONDS
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15 nA, was ineffective in restoring activity even though activation
by glutamate iontophoresis could still be elicited (n=4).

At

currents up to 15 nA, NE was also unable to reverse the inhibition
produced by intravenously administered LSD (10-15 ug/kg, n=6),
which is thought to inhibit 5-HT cell firing by stimulating 5-HT
autoreceptors (Aghajanian and Wang, 1978).
f.

Effects of Iontophoresis of A1pha-Adrenoceptor
Antagonists on 5-HT Cell Activity
Adrenergic terminals have been demonstrated within

the dorsal raphe.

Thus, the suppressant effects produced by the

systemic administration alpha-adrenoceptor antagonists could result
from the blockade of NE released from these terminals.

Therefore

the effects of alpha-adrenoceptor antagonists were examined when
they were iontophoretically applied in the vicinity of 5-HT cells.
Iontophoresis of alpha-antagonists, but not sotalol, a f-adrenoceptor
antagonist (Lish et al., 1965), gradually, totally, and reversibly
suppressed 5-HT cell firing (Table 2).

Iontophoretic application

of NE from 6-barrel electrodes effectively restored 5-HT cell firing
during a period of suppression produced by alpha-antagonists (fig.
6).

Since 5-HT cells have been found to be inhibited by 5-HT

(Aghajanian et al., 1972b),it was of interest to determine whether
these agents might be stimulating 5-HT autoreceptors and thereby
reducing 5-HT cell firing.

However, in contrast to the ability of

NE to reverse the effects of alpha-adrenoceptor antagonists.
(10-15 nA) did not diminish the inhibition produced by 5-HT
iontophoresis (n=6).

This observation supports the contention
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Figure 6:
Suppression of 5-HT cell firing by iontophoresis of alphaadrenoceptor antagonists.

Iontophoretic application of piperoxan,

thymoxamine, WB-4101 , phenoxybenzamine, phentolamine (PHE), and
dihydroergocryptine (DHK) produced complete suppression of 5-HT
cell firing.

Iontophoretic application of NE surmounted this

competitive blockade.

However, NE was less effective following

iontophoresis of dihydroergocryptine than after the application of
the other alpha-adrenergic antagonists tested.

SPIKES PER 10 SECONDS

10MINUTES
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that alpha-adrenoceptor antagonists act independently of the 5-HT
autoreceptor.

Of note was the observation that the reversal of

dihydroergocryptine by NE was less complete than that produced with
other alpha-adrenoceptor antagonists tested.

It is possible that

dihydroergocryptine may share agonist activity at the 5-HT auto¬
receptor with another ergot alkaloid, LSD.
g.

Ability of Adrenergic Agonists to Restore 5-HT Cell
Activity During Alpha-Adrenoceptor Blockade
The ability of adrenergic agonists to reverse the

suppressant effects of iontophoretically applied WB-4101 was tested.
Each agonist was compared with NE on the same cell.

The response

to each drug was defined as the highest average firing rate observed
during three consecutive 10 sec intervals.

Phenylephrine (PE), a

selective ^-agonist (Furchgott, 1972) was nearly eguipotent to NE
when applied at the same current and duration.

The ratio of the

PE response to that of NE was 0.85 + 0.16 (mean + SEM, n=6).

Under

these conditions, phenylephrine's action lasted more than twice
as long as that of NE, possibly due to less efficient inactivation
mechanisms (Trendelenburg, 1972 ; Tye et al ., 1967). ct-Methyl nore¬
pinephrine was less than one-fourth as potent as NE when tested at
the same current and duration (n=5).

Isoproterenol, a strong

6-agonist which possesses activity at alpha-adrenergic receptors
at high doses (Trendelenburg, 1974; Bevan et al., 1977) produced
only a weak activation even when administered for twice as long at
twice the current used for NE (n=5).

Salbutamol, another selective

6-agonist (Cullum et al., 1969; Brittain et al., 1970) was unable
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to produce activation under the same conditions used for isopro¬
terenol

(n=7) (fig. 7).
h.

Blockade of NE Activation of 5-HT Cells by AlphaAdrenoceptor Antagonists
Systemic administration of reserpine has been found

to suppress 5-HT cell firing (Aghajanian and Haigler, 1972).

Fol¬

lowing cessation of activity, NE iontophoresis restored 5-HT cell
firing (Section I of Experimental Studies).

Since spontaneous

5-HT cell firing may be dependent on NE released from terminals
present within the dorsal raphe, the effects of a-adrenoceptor
antagonits was examined on 5-HT cell activity which is clearly de¬
pendent on NE applied iontophoretically in the vicinity of 5-HT
cells.

Reserpine (5 mg/kg, i.v.) was administered causing a

suppression of 5-HT cell firing activity.

Then, 5-HT cells were

located by intermittent iontophoresis of glutamate from 5-barrel
electrodes.

This procedure caused a transient train of spikes.

Iontophoresis of NE ( < 10 nA for 1 min) produced a resumption of
firing activity in all 5-HT cells located in this manner (n-15).
Low doses of WB-4101

(1-5 nA for 1-5 min, n=5) and phentolamine

(1-2 nA for 1-3 min, n=6) blocked the activation of 5-HT cell
firing by NE by more than 50% but did not alter the ability of
glutamate to excite these cells (fig. 8).
3.

Piscussion
The results of this section support the hypothesis that

the firing activity of 5-HT neurons in the dorsal raphe is dependent
on the tonic activation of alpha-adrenoceptors.

A chemically
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Figure 7:
Reversal of suppression of 5-HT cell firing by adrenergic
agonists.
firing.

Iontophoresis of WB-4101 totally inhibited 5-HT cell
A nearly constant degree of blockade was maintained by

the use of low retaining currents.

Phenylephrine (PE) was

almost as potent as NE in restoring activity (top panel) whereas
isoproterenol

(ISO) was only weakly active (middle panel).

Furthermore, salbutamol

(SALB) was totally ineffective in restoring

activity (bottom record).
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Figure 8:
Blockade of NE activation of 5-HT cell firing by alphaadrenoceptor antagonists.

Following suppression of 5-FIT cell

firing by reserpine (RES: 5 mg/kg, i.v.) iontophoresis of NE
restored firing.

The al pha-adrenoceptor antagonist piperoxan

(PIP: 4 nA) blocked NE activation of 5-FIT cell firing (top
panel).

Blockade of NE activation following reserpine (5 mg/kg,

i.v., not shown) is also demonstrated for the alpha-antagonists
phentolamine (PHE, 2 nA) and WB-4101

(WB, 1 nA) (bottom panel).

Furthermore, the excitation produced by glutamate (G) was
unaltered by these drugs, demonstrating the specificity of their
blockade.
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diverse group of alpha-adrenoceptor antagonists suppressed the
firing of 5-HT cells in the dorsal raphe when administered either
systemically, or iontophoretically in the vicinity of 5-HT cells.
Previous anatomical studies have demonstrated that the dorsal raphe
receives an adrenergic input.

Together, these observations suggest

that NE terminals present within the dorsal raphe could mediate a
tonically active adrenergic influence on 5-HT cells located there.
The potency of systemically applied drugs in suppressing 5-HT
cell firing is WB-4101

> piperoxan - thymoxamine.

This ranking

correlates well-with other measures of alpha-adrenoceptor blocking
activity.

In the vas deferens, WB-4101 is much more potent than

thymoxamine (Mottram and Kapur, 1975), and piperoxan and thymoxamine
are of roughly similar potency at post-synaptic sites in the peri¬
phery (Drew, 1976).

Upon iontophoretic application of these drugs

in the dorsal raphe, WB-4101 retained a much greater potency than
either piperoxan or thymoxamine.

Interestingly, systemically

applied dihydroergocryptine and phentolamine failed to elicit signi¬
ficant changes in firing at doses which cause significant peripheral
alpha-receptor blockade.

However, the dramatic increase in effects

displayed by phentolamine and dihydroergocryptine, when they were
applied iontophoretically, suggests that they possess activity at
this central site, but penetrate the brain poorly.

This interpre¬

tation is supported by the behavioral studies of Rothlin (1946)
and the biochemical studies of Anden and Strombom (1974).
The possibility that the effects of systemically administered
agents stem from peripheral alpha-adrenergic agents stem from
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peripheral alpha-adrenergic blockade is unlikely, because (1)
when these agents were administered iontophoreticaly they had
similar effects, and (2) phentolamine at doses which produce alphaadrenoceptor blockade peripherally but apparently penetrate the
brain poorly was devoid of effects on 5-HT cell firing.
The delayed onset of action of phenoxybenzamine and prolonged
effect in the dorsal raphe following systemic administration is
consistent with a similar pattern observed in the periphery
(Nickerson, 1962).

The reduction in 5-HT cell firing produced was

not reversible by either amphetamine or NE as would be expected for
a nonequilibrium blockade (Nickerson, 1957).

However, following

short term iontophoretic application the inhibition produced was
of a reversible nature, as reported by Bevan et al.

(1977) in

another area.
The results of this section suggest that the release of NE
from adrenergic terminals present within the dorsal raphe maintains
5-HT cell firing activity.

However, iontophoresis of NE in the

vicinity of these 5-HT neurons has been previously reported to
produce variable effects on their firing rate.

At first glance,

these findings appear to be inconsistent with the suggestion that
the adrenergic input to the dorsal raphe activates 5-HT cells.
However, the results of this study reveal that at low currents,
NE exerts predominantly an activating influence on their sponta¬
neous firing activity.

In addition, NE can reverse the suppression

of 5-HT cell firing produced by reserpine.

Several lines of

evidence indicate that the activation of 5-HT cells by NE is
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mediated by alpha-adrenoceptors: (1) NE reverses the suppression
produced by alpha-adrenoceptor antagonists when they are administered
either systemically or iontophoretically; (2) phenylephrine, another
alpha-adrenoceptor agonists, shares ability of NE to reverse the
suppression produced by an alpha-adrenoceptor antagonist, WB-4101;
(3) alpha-adrenoceptor antagonists block the activation of 5-HT
cells by NE following the administration of reserpine.

This demon¬

stration that alpha-adrenoceptors mediate the activation by NE
further strengthens the hypothesis that the adrenergic system exerts
an activating influence on 5-HT cells in the dorsal raphe.

It is

unclear whether the depressant effect observed at higher levels
of NE has any physiological significance.
Since the 5-HT cells of the dorsal raphe respond to alphaadrenoceptor blockade, both locally and systemically, they provide
a potentially useful means of evaluating physiologically the central
alpha-adrenoceptor antagonist properties of drugs.

The pharmacology

of this receptor resembles that of the classical post-synaptic
a-adrenergic receptor found in the periphery. Alpha-adrenergic
receptors located in the locus coeruleus have been classified in
the alpl^-category (Cedarbaum and Aghajanian, 1977) proposed
by Larger (1974) and Starke et al.

(1975).

In the locus coeruleus

a-MNE is more potent than NE, while PE is only weakly active.
In contrast, in the dorsal raphe a reversal of this rank
ordering was observed:

PE is nearly equipotent to NE, while

a-MNE is only weakly active.

This suggests that this re¬

ceptor may be of the alpha-1 type.

In addition, WB-4101 and
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thymoxamine exhibit preferential blockade of aj-receptors (Kapur
and Mottram, 1 978; Drew, 1 977; Marshall et al., 1978).
If 5-HT cell firing is dependent on adrenergic tone, then
destruction of the adrenergic input to the dorsal raphe by 6-OHDA
should and does suppress firing.

However, the ability of 5-HT

cells to adapt to the chronic loss of adrenergic tone and resume
an apparently normal pattern of firing remains unexplained.

The

inability of drugs which act pre-synaptically i.e., reserpine and
low doses of clonidine, to suppress firing following 6-OHDA pre¬
treatment (Section I of Experiments) (Svensson et al., 1975),
suggests that 5-HT cell firing has become independent of adrenergic
tone.

However, the partially retained ability of al pha-adrenoceptor

antagonists which act postsynaptically to suppress firing activity
favors the notion that some adrenergic component still contributes
to maintaining 5-HT cell firing.

Further study of the manner in

which 5-HT cells adapt to the chronic loss of adrenergic tone is
needed to explain these pharmacological responses.
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III.

Suppression of Serotonergic Neuronal Firing by A1pha-Adrenoceptor
Antagonists: Evidence Against GABA Mediation
1.

Introduction
The pharmacological studies presented above suggest that

the noradrenergic (NE) innervation of the dorsal raphe (Fuxe, 1965)
plays an essential role in maintaining the tonic activity of the
serotonin (5-HT)-containing cells located there.

The demonstration

that a variety of al pha-adrenoceptor antagonists, when applied
iontophoretically in the vicinity of 5-HT cells, completely suppress
their spontaneous firing activity supports this hypothesis.

Also,

iontophoretic application of NE or the alpha-adrenoceptor agonist,
phenylephrine, readily reverses the suppression of 5-HT cell firing
produced by WB-4101, an alpha-adrenoceptor antagonist.

These

physiological findings imply that local changes in noradrenergic
transmission within the dorsal raphe can strongly influence the
tonic firing of 5-HT cells.
As the dorsal raphe contains non-serotonergic, as well as
serotonergic neurons (Aghajanian et al., 1978) the tonic activation
of 5-HT cells by the NE innervation could stem from either a direct
action of NE on 5-HT cells themselves or from an indirect action
involving interposed non-serotonergic neuronal elements.

The

systemic administration of picrotoxin, a GABA antagonist, has
been reported to partially reverse the suppression of 5-HT cell
firing produced by systemically applied alpha-adrenoceptor anta¬
gonists; this finding led to the proposal that GABA might mediate
the suppression of 5-HT cell firing produced by alpha-adrenoceptor
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blockade (Gallager and Aghajanian, 1976b).

This model postulates

that alpha-adrenoceptor antagonists act by blocking NE's tonic
inhibition of GABA-ergic interneurons within the dorsal raphe,
allowing them to fire; these disinhibited interneurons then
directly inhibit the 5-HT cells.

Recent biochemical and anatomical

studies which have demonstrated the presence of GABA-ergic neurons
with the dorsal raphe provide a basis for this scheme of NE's
action (McGeer et al., 1979; Bel in
1980).

et al., 1979; Gamrani et al.,

Also, the population of non-serotonergic neurons in the

dorsal raphe which displays a firing pattern reciprocal to that
of 5-HT cells (Aghajanian et al., 1978) could fill the role
assigned to the postulated interneuron.
The interneuron model predicts that blockade of GABA receptors
present on 5-HT cells should reverse the suppression of 5-HT cells
produced by alpha-adrenoceptor antagonists.

Alternatively, if

NE regulates firing by a mechanism which is independent of GABAergic transmission, then blockade of GABA receptors would not be
expected to alter the suppression of 5-HT cells produced by
alpha-adrenoceptor antagonists.

The previous physiological studies

would seem to favor the first alternative as the GABA antagonist,
picrotoxin, at least partially reversed the suppression of 5-HT
cell firing induced by alpha-adrenoceptor antagonists (Gallager
and Aghajanian, 1976b).

However, these results are not conclusive

as picrotoxin was given systemically and could have acted at sites
ouside the dorsal raphe to restore 5-HT cell firing.

In order

to distinguish more precisely between these alternatives, we have
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examined the effect of iontophoretically applied GABA antagonists
on the suppression of 5-HT cell firing produced by alpha-adrenoceptor
antagonists.
2.

Results
a.

Suppression of 5-HT Cell Firing by Alpha-Adrenoceptor
Antagonists:Specificity of ME Reversal
Consistent with previous reported results, microion-

tophoretic application of the alpha-adrenoceptor antagonists,
phentolamine and WB-4101, rapidly and totally suppressed 5-HT cell
firing (Section II of Experiments).

Although these drugs share

potent alpha-adrenoceptor antagonist activity, it was of interest
to provide experimental evidence that they suppress 5-HT cell
firing by blocking alpha-adrenoceptors and not by exerting a general
depressant action.

For example, phentolamine has been reported to

produce local anesthetic effects (Curtis, 1963).

However, at

currents used in this study (Table 3), a decrease in spike height,
indicative of a local anesthetic effect was not observed during
application of either drug.

On the other hand, if the action of

these drugs stems from alpha-adrenoceptor blockade, then NE should
be able to reverse the competitive blockade produced by these
drugs.

In agreement with previous results (Section II of Experi¬

ments), iontophoretic application of NE ( £ 10 nA), during the
suppression of 5-HT cell activity produced by phentolamine or
WB-4101, rapidly restored firing to a level close to their initial
rates (Table 3, Fig. 9, top panel).
The assumption that NE restored firing by its action at
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alpha-adrenoceptors and not by a general excitatory action was
also examined.

NE was not able to reverse the effects of 5-HT or

GABA (Table 3, Fig. 9), two substances also known to suppress the
firing of 5-HT cells (Aghajanian et al., 1972b; Gallager and
Aghajanian, 1976b).

In addition, the effects of NE were found to

differ from those of glutamate, an excitatory transmitter.

While

low doses of NE produced modest elevations in the baseline firing
rate of 5-HT cells, NE's action on these cells became more pro¬
nounced during the suppression of firing produced by alpha-adrenoceptor blockade (Section II of Experiments).

In contrast, glutamate's

excitatory action was reduced during the inhibition produced by
either GABA (n=3), 5-HT (n=2) or the alpha-adrenoceptor antagonists
WB-4101

(n=6) and phentolamine (n=5) (Fig. 9).

As shown in the

top panel of Figure 1, NE restored the excitatory effects of
glutamate as well as the baseline firing rate in the presence of
phentolamine.
b.

Effect of GABA and Glycine Antagonists on the
Suppression of 5-HT Cell Firing Produced by AlphaAdrenoceptor Antagonists
If the release of GABA mediates the suppression of

firing produced by alpha-adrenoceptor antagonists, then iontophoretic
application of GABA antagonists would be expected to restore firing.
Therefore, the ability of the GABA antagonists, picrotoxin (Galindo,
1969) and N-methyl bicuculline (Pong and Graham, 1972; Johnston
et al., 1972) to reverse the suppression of firing produced by
WB-4101 and phentolamine was examined.
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Table 3:

Suppression of 5-HT Cell Firing by Alpha-Adrenoceptor
Antagonists, 5-HT, and GABA: Selectivity of NE Reversal

Current
(nA)

Drug

1-15

WB-4101
Phentolamine
5-HT
GABA

Table 3:

0.2-5
1-10
0.3-5

Duration
(min)

NE
Reversal

1-3

13/13

1-5

12/12

0.25-2
0.5-5

0/5
0/14

The ranges of current and duration parameters used for
several drugs which suppress 5-HT cell firing are noted.
NE ( <_10 nA, 1-2 minutes) was applied during the
suppressed activity produced by the drugs listed.

NE

reversal of 5-HT cell suppression was defined as the
restoration of firing rates to greater than one-half
of baseline rate.
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Figure 9:
Suppression of 5-HT cell firing by phentolamine, 5-HT, or
GABA: selectivity of NE reversal.

Iontophoretic application of

either phentolamine (PHE, 2.0 nA) 5-HT (2, 4, and 8 nA) or GABA
(1, 2, and 4 nA) suppressed 5-HT cell firing.

NE reversed the

suppression produced by phentolamine but not by 5-HT or GABA
(0.002 M in 0.1 M NaCl), demonstrating the selectivity of NE's
reversal.

In addition, the effect of suppression of firing on

the response to glutamate is demonstrated.

In each record, pulses

of glutamate (G) which elicited a moderate excitation were applied
at regular intervals.

The absolute increase in rate produced by

glutamate was reduced during suppression of firing.

Note that

glutamate's effect returned to its initial level when the firing
rate was restored by NE (top trace) suggesting that the decrease
in gluatamate's response was not due to a general depressant
action of phentolamine.
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Picrotoxin (2.5-5 nA; 2 min) selectively antagonized GABA's
inhibitory action (Fig. 10).

It produced nearly total blockade of

GABA's action without decreasing the inhibitory response to 5-FIT
(n=6) consistent with previously reported results (Gallager and
Aghajanian, 1976b).

However, even doses of picrotoxin which ex¬

ceeded those necessary to block GABA (5-10 nA, 3-10 minutes)
failed to reverse the suppression of firing produced by either
WB-4101 (n=7) or phentolamine (n=5) (Fig. 11).

Higher currents of

picrotoxin have been reported to interfere with the inhibitory res¬
ponse to 5-HT and to exert some depressant effects on baseline
firing (Gallager and Aghajanian, 1976b).
rents were not tested extensively.

Therefore, higher cur¬

However, in two cells studied,

even a high dose of picrotoxin (20 nA, 5 minutes) failed to reverse
the suppression produced by WB-4101.
N-methyl bicuculline (1-5 nA, 1 minute) also produced nearly
complete blockade of GABA's action on 5-HT cells without altering
their inhibitory response to 5-HT (n=10) (fig. 10).

It was observed

that application of higher doses of N-methyl bicuculline (5 nA,
1-5 minutes) (n=19) produced 20-100% increases in firing rate in
11 cells and less than 20% change in eight.

Following extended

periods of ejection (>5 minutes) N-methyl bicuculline (5 nA) tended
to disrupt the normal, regular firing pattern of 5-HT cells.

Since

N-methyl bicuculline increased baseline firing rate, any reversal
of the suppression produced by a-adrenoceptor blockade would have
to be evaluated in light of its activating effect.

In an attempt

to detect a specific reversal of the effects of alpha-adrenoceptor
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blockade by N-methyl bicuculline despite its more general excita¬
tory action, the response of each cell to this drug was monitored
before and during suppression of firing by either WB-4101
or phentolamine (n=5).

(n=9)

However, the absolute increase in firing

rate produced by N-methyl bicuculline (5 nA, 2-4 minutes) during
the suppression of firing was only equal to or less than that
produced on baseline firing (Fig. 11, bottom panel).

To further

explore the possibility that N-methyl bicucul1ine 1 s activating
effect stems from an action independent of NE mechanisms, NE was
applied in combination with N-methyl bicuculline during the
suppression of firing.

As shown in Figure 11

(bottom panel),

during the suppression of firing produced by phentolamine, N-methyl
bicuculline increased firing to a pleateau level, then NE produced
a further activation which was nearly identical to its effect
when applied alone.

Application of NE and N-methyl bicuculline

together produced an additive stimulatory effect equal to 94 + 1%
(mean + S.E.M.) of the sum of the responses to the individually
applied drugs (n=5).
Glycine potently inhibits 5-HT cell firing (Gallager and
Aghajanian, 1976b).

An alternative model for NE's regulation of

5-HT cells might substitute glycine for GABA.

Therefore, the

ability of the glycine antagonist, strychnine (Curtis et al.,
1968) to reverse the suppression of 5-HT cell firing by WB-4101
was also examined.

Strychnine has been demonstrated to potently

and selectively antagonize glycine's inhibition of 5-HT cell firing
(Gallager and Aghajanian, 1976b) (Fig. 10).

Application of only

■
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Figure 10:
Selective action of GABA and glycine antagonists.

The

selectivity of the GABA antagonists picrotoxin and N-methyl
bicuculline are demonstrated in the top two traces.

N-methyl

bicuculline (BIC, 2.5 nA) totally blocked the inhibitory response
to GABA (GA, 0.01 M in 0.1 M NaCl) without altering the response
to 5-HT (top trace).

Similarly, picrotoxin (PIC, 2.5 nA) did

not reduce 5-HT1s inhibition but totally blocked GABA's action
(middle trace).

Strychnine (STR, 2.5 nA) a glycine antagonist,

selectively blocked glycine's (GLY) action without diminishing
the response to GABA.

BIC 2.5
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Figure 11:
Effect of GABA antagonists on suppression produced by
alpha-adrenoceptor antagonists.

WB-4101

(PHE) suppressed 5-HT cell firing.

(WB) and phentolamine

Picrotoxin (PIC) did not

reverse the suppression while NE did, suggesting that GABA
does not mediate the suppression (top and middle traces).
In the bottom trace, N-methyl bicuculline (BIC) produced a
similar excitation before and during the suppression of 5-HT
cell firing caused by phentolamine.

Furthermore, when NE

and N-methyl bicuculline were applied together they produced
an additive effect suggesting that NE and N-methyl bicuculline
act by independent mechanisms.
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0.5
PIC 10

PHE 0.2
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1 nA of strychnine for 1 minute produced nearly complete blockade
of glycine's inhibitory action (n=4).

However, prolonged application

of strychnine (5-10 nA; 3-5 minutes) did not reverse the suppression
of 5-HT cell firing produced by WB-4101 (n=5).
3.

Piscussion
The physiological studies reported in this section provide

evidence against the proposal that GABA mediates the suppression of
5-HT cells by alpha-adrenoceptor antagonists.

According to this

model, blockade of GABA receptors present on 5-HT cells should re¬
verse this suppression of 5-HT cell firing.

However, iontophoretic

application of picrotoxin failed to interfere with the ability of
alpha-adrenoceptor antagonists to suppress 5-HT cell activity.
Similarly, N-methyl bicuculline produced no greater stimulation of
firing during this suppression than before.

Furthermore, the effects

of N-methyl bicuculline and NE were additive suggesting that these
agents act by independent mechanisms.

These findings strongly

suggest that GABA does not mediate the suppression of 5-HT cells
by alpha-adrenoceptor antagonists.

In addition, similar experi¬

ments with the glycine antagonist strychnine, suggest that glycine
is not involved either.
The physiological evidence that GABA is not involved in NE's
regulation of 5-HT cells is supported by the demonstration that
doses of GABA antagonists tested completely block GABA's inhibitory
action when applied iontophoretically.

However, it could be

argued that it may require higher concentrations of GABA antagonists
to block synaptic GABA transmission than iontophoretically applied
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GABA.

For this reason, doses of GABA antagonists which greatly

exceeded those necessary to effectively block iontophoretically
applied GABA were used.

Nevertheless, even excessive doses of

picrotoxin did not produce any decrease in the effects of alphaadrenoceptor blockade.

Also, low currents of NE, applied during

the suppression of firing produced by alpha-adrenoceptor antagonists
were able to restore 5-HT cell firing.

According to the model

proposed, NE would be acting by inhibiting GABA-transmission.
Therefore, it would be difficult to reconcile this model with the
observation that NE, but not high doses of GABA antagonists, was
able to reduce GABA transmission.
The observation that NE reversed the suppression of 5-HT cell
firing produced by phentolamine and WB-4101 provides evidence that
these drugs act by blocking alpha-adrenoceptors.

However, NE1s

reversal could stem from a general excitatory action.

The assumption

that NE1s reversal is specifically related to its action at alphaadrenoceptors is supported by two observations.
the suppression produced by 5-HT or GABA.

NE did not reverse

Second, NE1s action

differed from that of glutamate, an excitatory transmitter.

During

the suppression of firing produced by a-adrenoceptor antagonists,
glutamate's prominent excitation decreased while NE's limited acti¬
vation of baseline firing increased dramatically.

These findings

support the assertion that NE's reversal of alpha-adrenoceptor
antagonists represents a specific interaction of NE with these
drugs at alpha-adrenoceptors.
N-methyl bicuculline has been shown to inhibit brain acetyl-
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chol inesterase(Cvenneby and Roberts, 1973).

The increase in firing

observed in some 5-HT cells could stem from an enhancement of
synaptically released acetylcholine.

However, this explanation

seems unlikely since 5-HT cells are not excited by iontophoretically
applied acetylcholine (unpublished observations).

An alternative

explanation is based on previous studies which demonstrated that
5-HT cells receive GABA-ergic input (Wang et al., 1976; Wang and
Aghajanian, 1977b).

N-methyl bicuculline's activation of 5-HT

cells could result from a reduction of background GABA-mediated
inhibition.

However, this action of N-methyl bicuculline is not

shared by picrotoxin and therefore, it is uncertain whether this
effect results from blockade of GABA receptors.

Of note, the (-)

optical isomer of N-methyl bicuculline, which does not share GABA
antagonist properties with the commercially available (+) isomer
used in this study, does possess similar excitatory properties
(Collins and Hill, 1974).

Therefore, N-methyl bicucul1ine1 s acti¬

vation of 5-HT cells could stem from an action unrelated to GABA
blockade.
As mentioned above, picrotoxin, when administered systemically,
partially reverses the suppression of 5-HT cell firing produced by
alpha-adrenoceptor antagonists.

This observation led to the

suggestion that GABA neurons mediated NE's action.

However, the

results of the present study favor a more direct action of NE on
5-HT cells.

Certainly, picrotoxin administered systemically

could affect 5-HT cells indirectly through an action on other
neurons synaptically linked with the 5-HT cells.

Although it is
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not entirely clear which NE cell groups project to the dorsal raphe,
it is noteworthy that systemically administered picrotoxin activates
NE neurons in the locus coeruleus (unpublished observations).

Thus,

if picrotoxin activates NE systems which project to the dorsal
raphe, the increased NE tone could overcome a competitive adrenergic
blockade and restore 5-HT cell firing.
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IV.

Noradrenergic Innervation of Serotonergic Neurons in the
Dorsal Raphe: Demonstration by Electron-Microscopic Autoradiography
1.

Introduction
The dorsal raphe nucleus receives one of the heaviest

noradrenergic (NE) innervations in the brain.

This input has been

demonstrated by histofluoresence (Fuxe, 1965), biochemical

(Levitt

and Moore, 1979; Saavedra et al., 1 976; Versteeg et al., 1976), and
immunocytochemical technigues (Grzanna and Molliver, 1980; Swanson
and Hartman, 1975).

The physiological studies presented above

have suggested that the NE innervation plays an important role in
maintaining the tonic firing activity of serotonin (5-HT) containing
cells.

For example, interruption of NE transmission by local,

iontophoretic application of al pha-adrenoceptor antagonists totally
suppresses 5-HT cell firing, and the iontophoresis of NE readily
reverses this suppression (Section II of Experiments).

Since the

dorsal raphe contains both non-serotonergic, as well as serotonergic
neurons (Aghajanian et al., 1978), the NE input may regulate 5-HT
cells by a direct innervation of 5-HT cells themselves, or in¬
directly through an interposed non-serotonergic neuronal element.
For example, the population of non-serotonergic neurons within
the dorsal raphe which displays a firing pattern reciprocal to
that of 5-HT cells (Aghajanian et al., 1978) might receive the
NE innervation and mediate NE's activating effect on 5-HT cells.
In order to determine whether NE terminals innervate 5-HT
cells, it was essential to identify both NE terminals and 5-HT
neuronal elements simultaneously at the ultrastructural level.
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NE terminals were labelled using previously developed techniques
of electron microscopic autoradiography (Aghajanian and Bloom,
1966, 1967b;Descarries and Droz, 1968,1970a,1970b).

The selecti¬

vity of this autoradiographic method was evaluated in two ways in
this study: 1) by examining the effect of pretreatment with the
3
selective catecholamine neurotoxin, 6-OHDA, on H -NE labelling and,
3
2) by comparing the H -5-HT autoradiographic pattern to that
obtained with

3

H-NE.

Postsynaptic neuronal elements were identified

at an early stage of degeneration following treatment with a selec¬
tive 5-HT neurotoxin, 5,7-dihydroxytryptamine (Baumgarten and
Lachenmayer, 1972).

Therefore, with this combination of techniques,

both pre-synaptic NE terminals and post-synaptic 5-HT elements could
be identified in the same tissue.
2.

Results
a.

3
H -NE Autoradiography of the Dorsal Raphe
Examination of sections of the dorsal raphe processed

3
for light-microscopic H -NE autoradiography revealed small groupings
of grains throughout the entire nucleus.

Only a few labelled cell

bodies were present consistent with the observation of Nowaczyk
et al. (1978) (Figure 12, left panel).

Examination of sections

which were processed for EM autoradiography showed highly selective
localization of grain clusters over unmyelinated axons, prejunctional
varicosities and nerve terminals (Figure 13).

These terminals con¬

tained both small agranular and larger dense core vesicles charac¬
teristic of adrenergic nerve terminals and formed symmetrical
synaptic junctions.

Post-synaptic elements were commonly small or
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medium-si zed dendritic profiles.

Labelled-cell bodies were en¬

countered only infrequently, as expected from their sparse presence
in light autoradiograms.
3

b.

H -5-HT Autoradiography of the Dorsal Raphe
As a means of evaluating the selectivity of NE3

labelling, H -5-HT autoradiography was also performed.

Sections

of the dorsal raphe processed for light autoradiography showed
accumulation of radioactivity by cell bodies throughout the entire
nucleus.

In addition, the supraependymal layer, which is known to

contain 5-HT-accumulating terminals (Lorez and Richards, 1973;
Richards et al., 1973; Richards and Tranzer, 1974) was heavily
labelled (Figure 12, right panel).

At the ultrastructural level,

prominent labelling of cell bodies, dendrites, and unmyelinated
axons was apparent.

However, in contrast to the autoradiographic

3
pattern of labelling obtained with H -NE, 5-HT-1abel1ing nerve
terminals forming specialized synaptic junctions were not observed,
consistent with the report of Descarries et al. (1979).

Of note,

many small neuronal cell bodies did not show accumulation of radio¬
activity, in agreement with previous observations that non-serotonergic neurons are present within the dorsal raphe (Aghajanian et
al., 1978; Descarries et al., 1979; Gamrani et al., 1980).
c.

3
H -NE Autoradiography: Effect of 6-OHDA Pretreatment
In order to further evaluate the specificity of the

labelling obtained by NE autoradiography, the effects of pretreat¬
ment with the selective catecholamine neurotoxin, 6-OHDA (100 yg,
free base, 72 hr survival), on NE-labelling was examined.

This

93

Figure 12
Light autoradiography of H^-NE and H^-5-HT.

A H^-NE light

autoradiograph of the dorsal raphe (left panel) contains small
clusters of grains throughout the section, while only one cell

3
body is labelled (arrow).

In contrast, H -5-HT light autoradiograph

(left panel) displays prominent labelling of cell bodies.

In

addition, the supraependymal layer (arrow, right panel) is
labelled by H^-5-HT but not H^-NE.

Scale:

letter, A, denotes the aquaduct of Sylvius.
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The

<• *• j"'

*■VVr
--?*T .

« V*
T uU

.-1

■»A< k

•■».'

»-<•>'■• '

X
XW-A

L-w.% ■'/ ;'J v.v^a

#:•
'?i&*>0&£%-k$k
* V

^

•?.>v<'S-%ytr^^pyp«:--v

■’C :•/ ‘.-J u+zy-f
. ..''

■->

* *

*«-v

-

*

■ v

i

v

:■'

&?■&&&£■■

.:.»3^'V .;•

'!*

."■

; .■*'

%

95

Figure 13:
3

H -NE EM autoradiography of dorsal raphe.
NE-labelled terminals are shown.

Two examples of

In the top panel, a dendrite

is innervated by a heavily labelled terminal

(two arrows).

Of

note, a varicosity of the same axonal process is also labelled
at left (two arrowheads).

In the lower panel, a small dendrite

is innervated by a labelled terminal
terminal.

(arrow) and another unlabelled

In addition, a labelled unmyelinated process is also

included at left (two arrowheads).

Scale: 0.5 microns.
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treatment markedly decreased the density of NE varicosities ob¬
served by histofluoresence in the dorsal raphe (Figure 14).

When

sections of the dorsal raphe were examined by electron microscopy,
damaged nerve terminals were observed as previously described
(Bloom, 1971; Bloom et al., 1972) and the density of NE-labelled
terminals was reduced by two-thirds (Table 4).
d.

3
H -NE Autoradiography: Effect of 5,7-DHT Pretreatment
In order to determine whether NE-labelled terminals

innervate 5-HT cells, the effect of 5,7-DHT pretreatment (200 yg,
free base, 48 hr survival) on the postsynaptic elements was examined.
As previously described, this treatment produced marked, selective
degeneration of 5-HT cell bodies and dendrites in the dorsal raphe,
while small, presumably non-serotonergic, neurons as well as a
large portion of the neuropil were not affected (Aghajanian et al.,
1978).

Two-thirds of the NE-labelled terminals containing synaptic

specializations, innervated dendrites displaying darkened or
severely disrupted cytoplasmic features, characteristic of degenera¬
ting neurons (Figure 15, bottom panel).

One sixth synapsed on

undamaged dendrites, and for the remaining sixth the postsynaptic
profile was too small to classify reliably.

Of note, the density

of NE-labelled terminals observed in the dorsal raphe after 5,7-DHT
pretreatment did not differ significantly from that found in unlesioned tissue (Table 4).
3.

Piscussion
These anatomical studies provide evidence that the NE input

to the dorsal raphe directly innervates 5-HT neurons located there.
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Figure 14:
NE innervation of dorsal raphe: effect of 6-OHDA treatment.
Prominent NE innervation of the dorsal raphe is demonstrated in
a fluorescence micrograph (left panel).

6-OHDA pretreatment

(100 yg, free base; 7 days survival) markedly depleted NE innerva¬
tion as shown in the right panel.

Many of the remaining vari¬

cosities are swollen (arrow), characteriStic of damaged monoamine
processes.

Scale:

aguaduct of Sylvius.

100 microns.

The letter, A, denotes the

100

Figure 15:
3
H -NE EM autoradiography: effects of 5,7-DHT treatment.

An

example of a NE-labelled terminal innervating an undamaged dendrite
taken from unlesioned tissue, is shown in the top panel (arrow).
In addition an unmyelinated axonal profile is present in the
field (two arrowheads).

After 5,7-DHT pretreatment (200 pq, free

base; 48 hour survival; bottom panel), a damaged dendrite is shown
innervated by a NE-labelled terminal

(arrow).

Scale: 0.5 microns.
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3
NE terminals were labelled by H -NE EM autoradiography.

Further¬

more, 5-HT cells were identified following treatment with the
selective 5-HT neurotoxin, 5,7-DHT.

Examination of tissue in

which both labelling techniques were combined, revealed that twothirds of NE-labelled terminals, which formed synaptic junctions,
innervated degenerating dendrites.

This finding implies that the

NE terminals directly innervate 5-HT cells of the dorsal
Several

raphe.

lines of evidence suggest that the EM autoradiographic

method achieved selective labelling of NE terminals.

1) Lesioning

of 5-HT neurons by treatment with 5,7-DHT did not reduce the density
of NE-labelled terminals.

2) Treatment of animals with 6-OHDA

produced a marked reduction in the density of NE-labelled terminals.
The degree of NE terminal depletion following 6-OHDA treatment
correlates well with the estimate provided by biochemical measures
of H^-NE retention (Breese and Taylor, 1970; Uretsky et a 1 .,
3)

1971).

Furthermore, it is unlikely that NE-labelled terminals with

specialized junctions are serotonergic since in parallel auto¬
radiographic studies with 5-HT, no labelled terminals with
specialized junctions were observed, even though prominent labelling
of cell

bodies, axons and dendrites are present.

The serotonin neurotoxin 5,7-DHT was employed to damage 5-HT
neurons.

Biochemical

studies have provided evidence for the selec¬

tivity of this drug when used in combination with DMI
et al., 1975; Gerson and Baldessarini, 1975).
undamaged neurons in the dorsal

(Bjorklund

The presence of

raphe, which are presumably non-

serotonergic, provides anatomical evidence for a selective action.
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As well, the density of NE-labelled terminals in the dorsal raphe
was not altered by 5,7-DHT pretreatment providing further evidence
for a selective action of 5,7-DHT.
3

Autoradiographic studies of
raphe allowed two observations.

H-5-HT localization in the dorsal
First, these studies provide con¬

firmatory evidence for the presence of non-serotonergic neurons
within the dorsal raphe suggested by previous studies (Aghajanian
et a 1., 1978; Descarries et al., 1979; Gamrani et al., 1980; McGeer
et al., 1979).

Second, 5-HT labelled varicosities were not observed

to participate in synaptic junctions.

As seen with the peripheral

adrenergic terminals (Grillo, 1966), transmitter release may occur
in the absence of synaptic junctions.

Therefore, the postulated

role of 5-HT axon collaterals in the 'autoinhibition' of 5-HT cells
(Wang and Aghajanian, 1977b,1978) is not ruled out by this observati on.

SUMMARY AND CONCLUSIONS
Previous biochemical and physiological studies had indicated
that the 5-HT cells of the dorsal raphe are regulated by the brain's
NE system.

The studies presented above provide evidence that the

NE innervation of the dorsal raphe exerts a potent activating
influence on 5-HT cell firing activity.

In the experiments con¬

ducted in the first section, reserpine's suppression of 5-HT cell
firing was found to stem from a decrease in adrenergic transmission.
Therefore, this drug served as a useful tool in examining the effect
of restoring NE tone in the vicinity of 5-HT cells.

Small amounts

of NE, applied iontophoretically, restored 5-HT cell firing during
its suppression by reserpine, demonstrating a consistent and dramatic
physiological response of 5-HT cells to NE.

Blockade of this

response by adrenoceptor antagonists provides evidence that NE's
action is receptor-mediated.

In the

second

section, it was found

that a wide variety of alpha-adrenoceptor antagonists when applied
iontophoretically totally suppressed spontaneous 5-HT cell firing.
The demonstration that alpha-adrenergic agonists could reverse
this suppression confirmed the suggestion that the effect of these
drugs results from their blockade of adrenoceptors.

This finding

indicates that not only are 5-HT cells responsive to exogenously
applied NE but also that NE released from terminals in the dorsal
raphe is essential for maintaining the spontaneous firing activity
of 5-HT neurons.
Extensive pharmacological characterization of the response of
5-HT cells to adrenergic agonists and antagonists allowed the
105
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classification of the adrenoceptors mediating NE's action in the
alpha-1 category.

Since, 5-HT cells are responsive to both syste-

mically and iontophoretically applied alpha-1 adrenergic drugs,
monitoring the firing activity of 5-HT cells provides a potentially
useful method for evaluating the activity of drugs at central alpha-1
adrenoceptors.
There are several possible neuronal circuits through which
alpha-adrenoceptor antagonists might act to suppress 5-HT cell
firing.

A tonically active excitatory adrenergic input could ter¬

minate directly on 5-HT cells.

The ability of NE to produce ex¬

citation at alpha-adrenoceptors has been reported in the cortex
by Bevan et al. (1977).

In this case, the antagonists would act

by interrupting a tonically active, excitatory adrenergic pathway.
Alternatively, alpha-adrenoceptor antagonists could suppress 5-HT
cell firing by blocking the tonic inhibition by NE of local GABA
interneurons.

A similar action of NE on interneurons has been

proposed to mediate the indirect effects of NE on principal neurons
in both the ventral horn of the spinal cord (Jordan et al., 1977)
and the lateral geniculate nucleus (Nakai and Takaori, 1974).

In

the dorsal raphe, the presence of very high levels of glutamate
decarboxylase (Tappaz et al., 1976), within intrinsic GABA neurons
(Belin et al ., 1979; McGeer et al., 1979) is consistent with this
model.

Indeed, non-serotonergic interneurons which have a firing

pattern reciprocal to that of neighboring 5-HT cells have been
found which could receive the adrenergic input (Aghajanian et al.,
1978).

Therefore, further physiological and anatomical investigations
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were aimed at defining the synaptic microcircuitry of the dorsal
raphe in order to elucidate the mechanisms by which alpha-adreno¬
ceptor antagonists suppress the firing of 5-HT neurons.
Physiological experiments presented in Section III indicated
that the NE system controls 5-HT cell firing independently of
GABA-ergic transmission.

Application of GABA receptor antagonists

did not interfere with the suppression of 5-HT cell firing produced
by alpha-adrenoceptor antagonists.

This finding favors the proposal

that a direct innervation of 5-HT cells by NE terminals regulates 5-HT
cell firing.

Several observations support this alternative.

A simi¬

lar direct mechanism for NE's action at alpha-adrenoceptors has been
proposed in the facial motor nucleus which is lacking intrinsic
interneurons (McCall and Aghajanian, 1979).

Also, a direct NE in¬

nervation of 5-HT cells would be consistent with the ability of low
amounts of NE to invariably activate 5-HT cells when applied from
drug barrels situated near the 5-HT cell soma (Section II of Experi¬
ments).

If NE's principal site of action were on interneurons then,

assuming a variable spatial relationship between interneurons and
the drug barrel, NE might have been expected to produce a more vari¬
able response.

Finally, anatomical experiments using electron-

microscopic autoradiography have demonstrated that NE terminals in
the dorsal raphe innervate 5-HT cells directly.
These findings provide evidence that GABA-ergic interneurons
present in the dorsal raphe do not mediate NE's regulation of 5-HT
cells.

Instead, the activity of 5-HT cells is apparently controlled

by a balance of opposing GABA-ergic (Wang et al., 1976; Wang and
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Aghajanian, 1977b)and noradrenergic influences.

The concept of

independent and opposite NE and GABA influences on 5-HT cell
firing suggests two possible mechanisms which could underlie the
suppression of 5-HT cells during REM (paradoxical) sleep (McGinty
and Harper, 1976; Trulson and Jacobs, 1979): either an increase in
GABA-ergic tone or a decrease in noradrenergic tone could silence
5-HT cell firing.

Even though the origins of the NE innervation

to the dorsal raphe are not completely defined, it is of interest
that NE cells in the locus coeruleus are also quiescent during REM
sleep (Jones et al., 1979).

If the afferent NE systems display a

similar suppression during REM sleep, then this could account for
the reduction in 5-HT cell firing.

Further investigation will be

necessary to determine whether the suppression of 5-HT cell activity
during REM sleep stems from either of these suggested mechanisms.
The mechanism by which a direct NE innervation of 5-HT cells
could regulate their firing deserves consideration.

5-HT cells

displays a characteristic rhythmic firing which could be driven by
an endogenous pacemaker mechanism (Mosko and Jacobs, 1976).

Alpha-

adrenoceptors have been shown to mediate NE's facilitation of the
excitability of principal neurons in the facial motor nucleus (McCall
and Aghajanian, 1979), in the lateral geniculate nucleus (Rogawski and
Aghajanian, in preparation), and in the cerebral cortex (Waterhouse et
al., 1979).

Therefore, NE's regulation of 5-HT cell firing could

result from its facilitation of their endogenous pacemaker activity.
Further investigation will be necessary in order to determine the
ionic mechanisms underlying a direct noradrenergic regulation of
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5-HT cell activity.
In summary, these studies form the basis for the conclusion
that NE, released from terminals in the dorsal raphe activates
5-HT cells by stimulation of alpha-1 adrenoceptors, as diagrammed
in Figure 16.

Hopefully, this insight into the mechanism under¬

lying the regulation of 5-HT cells by the NE system will eventually
contribute to a better understanding of the role of these monoaminergic systems in the physiology and pathophysiology of the
central nervous system.

no
Figure 16:
Circuit diagram of dorsal raphe: the 5-HT cells of the
dorsal raphe are represented by two circles labelled 5-HT.
These are subject to 'autoinhibition' by 5-HT acting at
serotonin receptors which have been classified in the S2
category (Aghajanian, in press).

In addition, a local GABA

interneuron has been included which exerts an inhibitory
action, denoted by, (-), on 5-HT cells.

The NE innervation

directly activates (+), 5-HT neurons by stimulating alpha-1adrenoceptors (04).

o

DORSAL RAPHE
NUCLEUS
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